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1.1 Epigenetics 
Epigenetic mechanisms were originally described by the British embryologist C.H. 
tĂĚĚŝŶŐƚŽŶ ŝŶ  ? ? ? ? ĂƐ  ?ƚŚĞ ĐĂƵƐĂůinteractions between genes and their products, which 
bring the phenotype into being ? (Waddington, 1939). Today, epigenetics is defined as the 
study of mechanisms that involve changes in gene expression which are not accompanied 
by changes of the DNA sequence (Holliday, 1987). The fact that classical genetics alone 
cannot explain ƚŚĞĚĞǀĞůŽƉŵĞŶƚŽĨĂŶŽƌŐĂŶŝƐŵ ?ƐƉŚĞŶŽƚǇƉĞ, was exemplified by Fraga et 
al. and Humpherys et al., who showed that monozygotic twins or cloned animals can have 
different phenotypes and different susceptibilities to a disease although they exhibit 
identical DNA sequences (Mario F Fraga et al., 2005; Humpherys et al., 2001). Epigenetic 
mechanisms offer a partial explanation for these phenomena and by now, a range of 
different chemical modifications to deoxyribonucleic acid (DNA) and histones are known to 
be associated with changes in gene expression (see Figure 1.1). 
 
 
Figure 1.1: Epigenetic mechanisms: DNA methylation and histone modifications. 
Figure from (Qiu, 2006) 
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The most-studied epigenetic changes are DNA methylation and histone modifications. DNA 
methylation involves the addition of a methyl group from S-adenosylmethionin to the 5 
position of the cytosine pyrimidine ring or the number 6 nitrogen of the adenine purine ring 
(Holliday and Pugh, 1975). Histone modifications are post-translational enzymatic 
modifications of the histones by acetylation (addition of an acetyl group), methylation 
(addition of methyl group), phosphorylation (the addition of a phospholyration group) and 
ubiquitination (addition of an ubiquinitation protein) (Bártová et al., 2008). These epigenetic 
mechanisms are necessary for the development of higher eukaryotes and are particularly 
important in several key physiological processes, including regulation of gene expression, X-
chromosome inactivation, imprinting, as well as silencing of germline-specific genes and 
repetitive elements (Robertson, 2005). Detailed information about DNA methylation is 
provided in section 1.2. 
Inheritance is defined as the transmission of information between generations of organisms. 
Thus, the epigenetic property to be replicated during mitotic cell division should rather be 
considered as mitotic stability (Skinner, 2011). Mitotic stability of DNA methylation is 
comprehensively described in section 1.2. The ability of the epigenome (the overall 
epigenetic state of a cell) to be replicated between generations of species is called 
epigenetic meiotic inheritance (Bock and Lengauer, 2008). The pluripotency of cells of the 
early embryo is ensured by a reset mechanism of the epigenetic information after 
fertilization (Wolf Reik, 2007). This reprogramming enables embryonic stem cells (ES cells) 
to differentiate down to any pathway. Epigenetic meiotic inheritance occurs by an 
incomplete reprogramming in the early embryo (Morgan et al., 1999). Consequently, 
epigenetic patterns might be carried from parent to offspring. Meiotic inheritance was 
initially identified in plants (Bender and Fink, 1995). Bender and Fink described meiotic 
inheritance of DNA methylation patterns and their associated phenotypes of a gene family 
of the Wassilewskaija strain of Arabidopsis. They were able to show that methylated and 
silenced loci can be meiotically transmitted through self-pollination and outcrosses (Bender 
and Fink, 1995). Further research showed that DNA methylation patterns can be replicated 
over more than one generation (Johannes et al., 2009) (see section 1.5). However, the 
underlying functional mechanisms remain to be clarified. Epigenetic inheritance and stability 
and its impact on the cell population or associated physiology is part of recent epigenetic 
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research. Reik provided a fundamental insight into heritable aspects of epigenetic gene 
regulation in mammalian development (Wolf Reik, 2007). 
Interestingly, environmental factors are able to modify the epigenome of somatic cells 
(Skinner, 2011). The following section highlights environmental-based influences on 
epigenetic modifications. The replication of environmentally influenced epigenetic patterns 
by mitotic stability modifies the somatic cell differentiation and function throughout the 
development of an organism and its susceptibility to a disease (Jirtle and Skinner, 2007). 
Honeybees pose an interesting example for such an environmental-based alteration of a 
phenotype regulated by DNA methylation (Kucharski et al., 2008). Larvae predominantly fed 
royal jelly become more likely queens due to a specific signal cascade (Maleszka). Kucharski 
et al. pointed out that down-regulation of the DNA methyltransferase during larval 
development leads to an increased number of queens not fed royal jelly (Kucharski et al., 
2008). This study exemplifies a potential influence of nutrition on DNA methylation. 
Recent biological research shows the importance of studying epigenetic influences on 
complex diseases and aging (Flintoft, 2010) (see Table 1). Especially several potential links 
between epigenetic mechanisms and cancer have been identified so far (Manel Esteller, 
2008). A study in the field of aging research showed that age-dependent methylation 
patterns have an impact on neurologic disorders, autoimmunity, and the development of 
cancer in elderly people (Richardson, 2003). A tissue-specific loss of DNA methylation has 
been identified, which may lead to chromosomal instability and neoplasia and Richardson et 
al. stated that global DNA hypermethylation increases the risk of colon cancer with 
advancing age (Richardson, 2003). 
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Table 1: Associations between epigenetic modifications and human diseases. 
Table modified from (Rodenhiser and Mann, 2006) 
Disease/condition Gene Epigenetic process References 
Beckwith-Weidemann 
syndrome 
11p15 Imprinting (Weksberg et al., 2003) 
Breast cancer BRCA1 Hypermethylation (Mancini et al., 1998) 
Colon cancer Multiple 
genes 
Hypermethylation (M Esteller, Corn, et al., 2001) 
Leukemia p15 Hypermethylation (M Esteller, Corn, et al., 2001) 
Lung cancer p16, p73 Hypermethylation (M Esteller, Corn, et al., 2001) 
Prader-Willi syndrome or 
Angelman syndrome 
15q11-q13 Imprinting (Nicholls and Knepper, 2001) 
Shizophrenia RELN Hypermethylation (Sharma, 2005; Costa et al., 2002) 
Stomach cancer Cyclin D2 Hypomethylation (Oshimo et al., 2003) 
 
In summary, epigenetics involves the study of alterations in gene expression caused by 
heritable and non-heritable biochemical mechanisms, other than changes in the underlying 
DNA sequence. Recent research focuses on DNA methylation and histone modifications and 
their impact on transcriptional control. These mechanisms play a determining role in the 
development and growth of cells. It has been shown that epigenetic abnormalities pose a 
riskfactor for complex disease. 
 
1.2 DNA methylation 
Nowadays several research projects, such as the Human Genome Project, have sequenced 
various genomes (IHGSC, 2004). However the DNA sequence of an organism is insufficient to 
describe its phenotype. It is important to know when and where a specific gene will be 
transcribed. DNA methylation, as a heritable epigenetic modification, is able to control gene 
expression. It is the only known epigenetic mechanism that directly concerns the DNA 
without changing the underlying DNA sequence. 
DNA methylation involves the addition of a methyl group from S-adenosylmethionin to the 5 
position of the cytosine pyrimidine ring or to the number 6 nitrogen of the adenine purine 
ring (Holliday and Pugh, 1975). Eukaryotes solely make use of cytosine methylation, whereas 
in prokaryotes both cytosine and adenine can be methylated (Jeltsch, 2002). DNA 
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methylation in prokaryotes controls DNA replication and gene expression and has a 
protective function in terms of distinction of self and non-self DNA. This distinction has been 
associated with defense against bacteriophages (Arber and Linn, 1969). Such protective 
mechanism also exists in eukaryotes: transgenes, introduced into humans or mice, can be 
detected and silenced by DNA methylation (Kisseljova et al., 1998; Sasaki et al., 1993). Thus, 
this distinguishing mechanism seems to be conserved in evolution. 
During mitotic cell division, both genetic and epigenetic information must be replicated to 
daughter cells. This phenomenon results in differentiated states of cells and enables a 
normal development process. The enzyme DNA methyltransferase (DNMT) identifies DNA 
methylation patterns of the parental cell during the replication of the DNA (synthesis phase) 
and methylates the replicated strand of the daughter cell (Goll and T. H. Bestor, 2005). Goll 
and Bestor showed that especially repetitive DNA sequences and RNA-DNA interaction 
mediate the establishment and maintenance of DNA methylation by DNMT. Originally, the 
cytosine methylatransferase was identified in 1988 (T. Bestor et al., 1988) and so far several 
homologues of this enzyme are known. They are split into three groups categorized based 
on their C-terminal catalytic domains: DNMT1 family, DNMT3 family, and chromomethylase 
family (Goll and T. H. Bestor, 2005; Goll et al., 2006). Originally, DNMT2 was also identified 
as a DNA methyltransferase (Goll and T. H. Bestor, 2005), however, Goll et al. showed that 
DNMT2 acts as RNA specific methyltransferase (Goll et al., 2006). Meanwhile, DNMT2 is 
known as TRDMT1, which is the only identified RNA methyltransferase so far (Squires et al., 
2012). 
Human DNA methylation establishment and maintenance is regulated by DNMT1 and 
DNMT3 (T. Bestor et al., 1988). It has been shown that hemimethylated DNA (only one 
strand of a double-stranded DNA sequence is methylated) is much faster methylated than 
completely unmethylated DNA sequences (Stein et al., 1982). This maintaining mechanism is 
carried out by DNMT1, which involves a 5-30 times faster DNA methylation mechanism 
compared to de novo DNA methylation (Yoder et al., 1997). De novo DNA methylation in 
humans is mediated mainly by DNMT1 but can also be mediated by members of the DNMT3 
family, which consists of DNMT3A, DNMT3B, and DNMT3L (Okano et al., 1998; Goll and T. H. 
Bestor, 2005). In cancer, DNMT1 is used for de novo and maintaining DNA methylation of 
tumor suppressor genes (Jair et al., 2006; Ting et al., 2006). The DNMT3 family involves two 
different types of regulatory mechanisms. DNMT3A and DNMT3B mediate de novo and 
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maintaining DNA methylation of CpG dinucleotides (cytosine and guanine nucleotides 
separated by a phosphate). In contrast, DNMT3L does not involve any methyltransferase 
activity (Goll and T. H. Bestor, 2005). It especially regulates mechanisms in germ cells and is 
important for the establishment of maternal genomic imprinting patterns (Goll and T. H. 
Bestor, 2005). Goll and Bestor stated that DNMT3A and DNMT3B do not involve any 
sequence specificity beyond CpG dinucleotides (Goll and T. H. Bestor, 2005). 
In prokaryotes, DNA methylation regulates the mitotic replication process of the DNA 
sequence. After the replication, the synthesized strand is not directly methylated thereby 
allowing the mismatch repair system to differentiate between the template and nascent 
strands (Cooper et al., 1993). This self-adjusting error correction does not exist in eukaryotic 
organisms. Araujo et al. investigated whether there is also a lag between DNA replication 
and DNA methylation patterns by methyltransferase in mammalian cells (Araujo et al., 
1998). They stated that DNA methylation at CpG dinucleotides simultaneously occurs with 
the replication of the underlying DNA sequence. This tight coordination of genetic and 
epigenetic replication is characteristic for mammalian cells (Araujo et al., 1998). Methylation 
occurs independently of the genomic distance to the origin of the replication and prior to 
ligation of Okazaki fragments (short molecules of single-stranded DNA that are formed on 
the lagging strand during DNA replication). 
DNA methylation usually takes place at CpG dinucleotides (Pelizzola and Ecker, 2010). 
Almost a fifth (~19%) of all bases in the human reference (hg19/build37) DNA sequence are 
Cs and another 19% are Gs, whilst only ~1.8% of all dinucleotides are CpGs. The frequency of 
CpG dinucleotides is therefore much lower than expected based on the GC content (Bird, 
1980), which is due to the inherent mutability of methylated cytosines (Venter et al., 2001). 
Deamination of cytosine includes the hydrolysis reaction of cytosine into uracil, whereas 
spontaneous deamination of methylated cytosine results in thymine (Venter et al., 2001). 
Because uracils are a component of the RNA but not DNA, a mechanism exists, which 
recognizes and repairs deaminated cytosines, but deaminated methylated cytosines, namely 
thymines, remain unmodified (Singal and Ginder, 1999; Bird, 1980; Duncan and Miller, 
1980). As a consequence, methylated CpG sites are more likely to get lost during cell 
differentiation. 
Methylated CpG sites in the genome are not equally distributed. Regions characterized by a 
high G+C content and a high frequency of CpG dinucleotides, are called CpG islands (Bird, 
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1986). There are several numerical definitions of CpG islands but the most commonly used 
definition is: a CpG island is a genomic region with a G+C content of greater than 60% and a 
ratio of CpGs to GpCs of at least 0.6 (S B Baylin et al., 1998). Most of CpG islands are 
unmethylated and are often located within upstream regions of genes (Pelizzola and Ecker, 
2010). Hence, they have a strong impact on transcriptional gene regulation (Koga et al., 
2009). CpG sites within CpG islands usually involve weak DNA methylation levels in the germ 
line, which involves a protective mechanism regarding deamination of methylated cytosines 
during mitotic cell division (Fazzari and Greally, 2004). 
Methylated cytosines also occur outside of CpG dinulceotides. These sites are called non-
CpG methylation sites, whereas CHG and CHH (H being A, C or T) methylation sites involve a 
regulatory effect on transcriptional levels (Lister et al., 2009; Pelizzola and Ecker, 2010). 
Plants often exhibit an enrichment of methylated non-CpG sites, which mediate dynamical 
interaction with small interfering RNAs (siRNAs) (Koga et al., 2009). Variying distribution of 
CpG and non-CpG methylation frequencies can be found in different eukaryotic organisms, 
as exemplified in the following (see Table 2). A notably high amount of non-CpG methylation 
can be found in Physcomitrella patens, a moss plant, which exhibits 29.7% of methylated 
CHG and 23.2% of methylated CHH sites (Pelizzola and Ecker, 2010). Until today, non-CpG 
methylation in human genomes has predominantly been found in ES cells (Lister et al., 
2009). Almost 25% of all methylation sites in ES cells occur within non-CpG dinucleotides, 
which implicates further, so far unknown, regulatory mechanisms of methylation (Lister et 
al., 2011). Most often gene bodies show an enrichment of non-CpG methylation sites, 
whereby upstream regions of genes and protein binding sites are depleted (Lister et al., 
2009). Furthermore, non-CpG methylation disappears during cell differentiation and is re-
established in induced pluripotent stem cells (Lister et al., 2009) (see sections 1.2.1). 
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Table 2: Frequencies of CpG and non-CpG methylation in 23 eukaryotes. 
Table modified from (Pelizzola and Ecker, 2010) 
Eukaryotic organisms Genome size (Mb) mCpG mCHG mCHH 
Nematosella vectensis 297 9.4 0.16 0.15 
Mus musculus 2716 74.2 0.30 0.29 
Homo sapies 3080 67-82 0.09-2.8 0.04-0.9 
Tetraodon nigrovirdis 302 65.5 0.25 0.34 
Danio rerio 1563 80.3 1.22 0.91 
Ciona intestinalis 141 21.6 0.28 0.28 
Apis melifera 231 0.51 0.11 0.16 
Drosophila melanogaster 162 0.12 0.11 0.11 
Bombyx mori 431 0.71 0.08 0.09 
Tribolium castaneum 151 0.11 0.12 0.12 
Uncinocarpus reesii 22 0.67 - - 
7Coprinopsis cinerea 36 12.2 - - 
Phycomyces blakesleeanus 51 4.9 - - 
Selaginella moellendorffii 101 12.5 9.0 0.92 
Oryza sativa 372 50.0 27.4 5.2 
Arabidopsis thaliana 120 22.3 5.92 1.51 
Populus trichocarpa 485 41.9 20.9 3.25 
Physcomitrella patens 454 29.5 29.7 23.2 
Cholella sp. NC64A 42 80.5 2.2 0.25 
Volvox carteri 126 2.6 0.08 0.08 
Chlamydomonas 
reinhardtii 
120 5.4 2.59 2.49 
 
A modification of DNA methylation is the oxidation of 5-methylcytosine to 5-
hydroxymethylated cytosine (Ficz et al., 2011). Most of the methods, which are used to 
detect DNA methylation are inapplicable for the determination of hydroxymethylation 
patterns (Harris et al., 2010). Corresponding approaches make use of thin-layer 
chromotography (Jin et al., 2010). Hydroxymethylation is catalyzed by proteins of the ten-
eleven translocation (TET) family that are highly expressed in ES cells (Tahiliani et al., 2009). 
Recent studies showed that 5-hydroxymethylated cytosines are enriched in euchromatic 
parts of the genome including regulatory regions as for instance promoters and CpG islands 
(Ficz et al., 2011). Ficz et al. found out that frequent appearance of 5-hydroxymethylation 
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correlates with high expression level of the underlying DNA sequence. However, the 
underlying functional mechanism remains to be clarified. 
 
1.2.1 Human Methylomes 
Recent biotechnological developments in the field of next-generation sequencing enable 
cost-effective analysis of methylomes for multiple-gigabase genomes, like the human 
genome. Lister et al. provided the first genome-wide insight into DNA methylation at single-
base resolution in mammalian genomes in 2009 (Lister et al., 2009). They generated maps of 
methylated cytosines of human ES cells and fetal fibroblasts. Constitutive differences of 
DNA methylation patterns were identified for these two cell types (Lister et al., 2009). This 
primordial map of DNA methylation patterns can be used as a reference for methylomes of 
differentiated cell types. By now, additional human methylomes were analyzed, as for 
instance of human colon cancer cells and of human peripheral blood mononuclear cells 
(Hansen et al., 2011; Li et al., 2010). 
Typically, differences based on DNA methylation are associated with cell type specific 
patterns of CpG methylation. Lister et al. additionally detected substantial distinctions based 
on non-CpG methylation (Lister et al., 2009). ES cells exhibit an enrichment of methylated 
non-CpG sites compared to differentiated cells (Lister et al., 2009). Nearly 25% of all 
methylation sites in ES cells were within non-CpG dinucleotides, exhibiting an enrichment of 
CAH and CAG trinucleotides. They further reported the following sequence specificity of 
DNA methylation. CpG and non-CpG sites with a spacing of 8?10 bases were more likely 
methylated, whereas only for methylated CHG sites a periodicity of two pairs of 8-base 
separated cytosines with a spacing of 13 bases could be identified (Lister et al., 2009). Lister 
et al. found out that especially genes, involving a high transcriptional level, are affected by 
non-CpG methylation (Lister et al., 2009). More precisely, methylated CHH sites on the 
antisense strand in gene bodies were enriched, whereas CHG sites on the sense strand were 
almost exclusively unmethylated. Thus, non-CpG methylation might involve a stimulating 
effect on gene expression, in contrast to CpG methylation, which has a silencing effect. 
Lister et al. additionally identified specific CpG methylation patterns at exon-intron 
boundaries. These findings indicate the key role of non-CpG methylation in the origin and 
maintenance of ES cell as a pluripotent cell type. 
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A further publication of Lister et al. pursued the question whether similar DNA methylation 
properties, as they were observed in ES cells, also underlie induced pluripotent stem cells 
(iPSCs). They pointed out that iPSCs are subjected to a reprogramming mechanism for CpG 
and non-CpG methylation. Altogether, methylomes of iPSCs are very similar to those of ES 
cells (Lister et al., 2011). Nevertheless there are genomic regions, which exhibit differences 
in CpG DNA methylation patterns. Most of them are located in CpG islands and gene regions 
(Lister et al., 2011). These differentially methylated regions (DMRs) might be traced to 
transmission of incomplete reprogrammed somatic cell DNA methylation patterns or they 
might be even specific for iPSCs (Lister et al., 2011). Most of these DMRs were analyzed by 
analyzing independent iPSC lines. However, there seems to be unique DMRs for each iPSC 
line, which results in an interclone variability (Lister et al., 2011). Mega-scale genomic 
regions have been additionally indetified, which are resistant to reprogramming of non-CpG 
methylation patterns. These regions are also associated with histone modifications, such as 
H3K9me3, and transcriptional activity (Lister et al., 2011). In summary, CpG and non-CpG 
DMRs, varying histone modifications and expression patterns can be used as markers for 
incomplete reprogramming of iPSCs (Lister et al., 2011). 
 
1.2.2 DNA Methylation in Cancer 
Already in 1983 a first comparison of DNA hypomethylation (decrease of DNA methylation) 
in tumors and corresponding control tissue was published by Feinberg and Vogelstein (A P 
Feinberg and Vogelstein, 1983). Several articles have been published describing DNA 
hypomethylation in cancer (Bedford and van Helden, 1987; Cadieux et al., 2006). The 
opposite relative DNA methylation state, DNA hypermethylation, is especially associated 
with promoter regions of tumor suppressor genes (Graff et al., 1995; Melki et al., 1999; 
Costello et al., 2000). However, these gene-specific hypermethylated tumors additionally 
consist of genomic regions exhibiting predominant low DNA methylation (Manel Esteller, 
2008). Consequently, tumor methylomes cannot be categorized as DNA hypomethylated or 
DNA hypermethylated; they rather should be distinguished regarding their underlying 
genomic region. A large proportion of DNA hypomethylation is located within repetitive 
genomic regions, which are usually predominantly methylated (Hoffmann and Schulz, 2005). 
For example, satellites within pericentromeric heterochromatin of chromosome 1 are 
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predominantly unmethylated in many human cancers (N. Wong et al., 2001). There are 
several genes, which are affected by DNA hypomethylation in tumor cell lines, such as the 
unmethylated melanoma antigen family, which encode tumor antigens (De Smet et al., 
1999), the unmethylated S100 calcium binding protein A4 gene (S100A4) in colon cancer 
(Nakamura and Takenaga, 1998), the unmethylated serine protease inhibitor gene SERPINB5 
in gastric cancer (Akiyama et al., 2003), and the unmethylated oncogene ?-synuclein (SNCG) 
in breast and ovarian cancer (Gupta et al., 2003). In summary, DNA hypomethylation can be 
separated into three different mechanisms. It affects genomic instability early in 
tumorigenesis, reactivates transposable elements, and can lead to loss of imprinting (Manel 
Esteller, 2008). 
DNA hypermethylation of CpG islands, especially for those overlapping promoter regions of 
tumor-suppressor genes, is also often associated with cancer cells (Peter A Jones and 
Stephen B Baylin, 2007). Several DNA hypermethylated CpG islands overlapping promoter 
regions of cancer associated genes could be identified: the tumor-suppressor genes 
retinoblastoma Rb (Greger et al., 1989; Sakai et al., 1991), VHL (associated with von Hippel-
Lindau disease) and p16
INK4a 
(J G Herman et al., 1994; Merlo et al., 1995; J G Herman et al., 
1995; Gonzalez-Zulueta et al., 1995), hMLH1 (a homologue of MutL Escherichia coli) (James 
G Herman and Stephen B Baylin, 2003), and BRCA1 (breast-cancer susceptibility gene 1) 
(James G Herman and Stephen B Baylin, 2003; M Esteller et al., 2000). The Knudson two-hit 
hypothesis states that all copies of a tumor-suppressor gene have to be impaired to obtain a 
complete loss of function (Knudson, 2001). In genetics, such a phenomenon might be given 
by a germ-line (in familial cancers) or a somatic (in non-inherited tumors) mutation within 
the coding region of one of two copies of a tumor-suppressor gene. The second copy of the 
tumor-suppressor gene is usually affected by a somatic mutation, which ultimately leads to 
a malignant transformation of the cell (Knudson, 2001). DNA methylation of promoter 
regions of tumor-suppressor genes might act as a disruption, which has a similar effect as 
mutations within the coding region of the underlying gene (M Esteller, M F Fraga, et al., 
2001). In familial cancer types, DNA methylation usually interferes with the activity of a 
tumor-suppressor gene on the second level of the Knudson two-hit hypothesis i.e. the first 
copy is affected by an inherited mutation (M Esteller, M F Fraga, et al., 2001). Esteller et al. 
additionally verified several types of nonfamilial tumors, which involve two fully methylated 
promoters of an associated tumor-suppressor gene. Altogether, it can be concluded that 
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there are more cancer-related genes influenced by DNA methylation than by mutations 
(Peter A Jones and Stephen B Baylin, 2002; Merlo et al., 1995). 
Several epigenetic research projects identified hundreds of cancer genes associated with a 
DNA hypermethylated promoter region. Even an individual tumor type might include a 
variety of DNA hypermethylated loci. Recent cancer biology assumes that the stem cell state 
is an integral component of cancer development (Manel Esteller, 2008). Baylin and Ohm 
reviewed contributions of epigenetically silenced groups of genes at the chromatin level, 
which control the maintenance of cells in a stem cell state (Stephen B Baylin and Ohm, 
2006). dŚĞ ĐŽŶĐĞƉƚ ŽĨ ƚŚĞ  ?ĐĂŶĐĞƌ ƐƚĞŵ ĐĞůů ?involves the cell population which is 
responsible for perpetuating the tumor (Bjerkvig et al., 2005). Cancer stem cells might 
originate from tissue-specific and bone marrow stem cells. Furthermore they might be 
derived from somatic cells that undergo transdifferentiation processes, or they are the 
result of cell fusion or horizontal gene-transfer processes (Bjerkvig et al., 2005). An accurate 
distinction of cancer stem cells and normal stem cells remains to be clarified.  
The strong association of DNA methylation and cancer raises the request of epigenetic 
therapeutics. Especially drugs involving a reduction of DNA methylation is of great interest, 
since it could reverse gene silencing of tumor-suppressor genes. Constantinides initially 
described the impact of azanucleoside drugs on the expression level of cells in 1977 
(Constantinides et al., 1977). In the meantime, it has been proven that treatment of 5-
azacytidine has an inhibiting effect on DNA methylation (Santi et al., 1983). Further DNA 
methylation influencing drugs, such as fluoro- ? ?-deoxycytidine (P A Jones and Taylor, 1980) 
and zebularine (Cheng et al., 2004), are currently in development. A disadvantage of such 
nucleosides is their need to be incorporated directly into the DNA to exploit their full 
capability. Consequently, there have been several alternative attempts to develop drugs 
acting without any direct incorporation into DNA. Procainamide (Cornacchia et al., 1988) 
and tea polyphenols (Fang et al., 2003) include a DNA methylation inhibiting effect. 
However they solely have a weak effect on living cells (Peter A Jones and Stephen B Baylin, 
2007). 
 
Introduction 
14 
1.3 Genomic Imprinting 
Genomic imprinting is a epigenetic mechanism, that regulates gene expression in a parental-
origin-specific manner (Ferguson-Smith, 2011). Either the maternal or the paternal allele is 
transcribed while the respectively other allele is silenced by an epigenetic mechanism. Thus, 
imprinting does not follow Mendelian rules. Originally, this phenomenon was discovered in 
experiments with mouse embryos that contain only one of the two sets of parental 
chromosomes (uniparental embryos) and those that inherit solely specific chromosomes 
from one parent (uniparental disomy) (Surani et al.; McGrath and Solter, 1984). Both 
experiments showed that genes have different properties and effects depending on their 
parental origin. 
In 1991, the first imprinted genes could be identified, which are expressed in a parental-
specific manner (DeChiara et al., 1991; Barlow et al., 1991; Bartolomei et al., 1991). Today, it 
is known that genomic imprinting takes place in several mammalian organisms (W Reik and 
Walter, 2001). Today, especially DNA methylation is associated with genomic imprinting. 
Parental-specific incomplete reprogrammed DNA methylation patterns in the embryo result 
in varying gene expression levels of differentiated cells. Figure 1.2 exemplifies a hypothetical 
pedigree of familial inheritance of an imprinted disorder through five generations. In this 
case, the mutation takes place in a paternally imprinted gene. Hence a paternal mutation 
cannot affect the offspring, since it is repressed. 
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Figure 1.2: Hypothetical pedigree of inheritance of an imprinted disorder. 
Figure modified from (Aitman et al., 2011) 
 
Until today, especially imprinting in mice was studied and plenty of imprinted genes have 
been identified. A subset of these genes have even been validated in other mammalian and 
also in the human genome (Killian et al., 2000). Notably 80% of the imprinted genes 
annotated in the mouse cluster in specific genomic regions (Killian et al., 2000). Besides 
their affinity to appear in clustered groups, there is an enrichment of imprinted genes 
covering CpG islands that are located close to repeated genomic regions (Paulsen et al., 
2000). Most of the imprinted genes show differences in maternal and paternal DNA 
methylation patterns. However, it should be distinguished between imprinted genes 
established from parental germ cells and maintained during cell differentiation (Stöger et 
al., 1993; Olek and Walter, 1997; Tremblay et al., 1997; Shemer et al., 1997) and imprinted 
genes, which initially exhibit equal parental DNA methylation patterns and evolve into 
tissue-specific imprinted genes (R Feil et al., 1994). Another property of the imprinting 
mechanism is observed during the cell division process. Kitsberg et al. observed a time-
related property of imprinted genomic regions (Kitsberg et al., 1993) with a temporary shift 
in the replication of imprinted genomic regions during the cell cycle. The replication of the 
paternal copy usually occurs before the maternal one. Furthermore, it has been noted that 
Male Female Affected Carrier
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parental-specific meiotic recombination rates arise during the synthesis of imprinted 
genomic regions (Pàldi et al., 1995; Robinson and Lalande, 1995). 
It is certainly of great interest to understand the impact of genomic imprinting on an 
ŽƌŐĂŶŝƐŵ ?ƐƉŚĞŶŽƚǇƉĞ ? human disorder that shows parental-origin effects, due to genomic 
imprinting, is the Beckwith-Wiedemann syndrome (BWS) (Lubinsky et al., 1974). Lubinsky et 
al. reported:  ?ĂĨĨĞĐƚĞĚŽĨĨƐƉƌŝŶŐŽĨĞŝƚŚĞƌƐĞǆďŽƌŶŽŶůǇƚŽĨĞŵĂůĞďƵƚŶŽƚƚŽŵĂůĞĐĂƌƌŝĞƌƐ ?
(Lubinsky et al., 1974). This disorder is additionally associated with an increased incidence of 
childhood tumors. However, BWS, a sporadic disease, is additionally associated with 
genomic alterations within the region 11p15 and is not only caused by imprinting (Michael R 
DeBaun et al., 2002). Chromosomal rearrangements, paternal uniparental disomy (maternal 
copy of chromosome 11 is replaced by the paternal one), or the presence of only one gene 
within the 11p15 region might also cause BWS (M R DeBaun and Tucker, 1998). 
Neurological disorders, such as the Prader-Willi syndrome and the Angelman syndrome, 
have as well been identified as diseases regulated by imprinted genes (Buiting et al., 1995). 
Both disorders are caused by genetic and epigenetic defects within the same genomic 
domain on human chromosome 15. However, they differ in their parental-origin-specific 
manner.  The Prader-Willi syndrome occurs in ~1 in 20,000 births and is characterized  ?by a 
failure to thrive during infancy, hyperphagia and obesity during early childhood, mental 
ƌĞƚĂƌĚĂƚŝŽŶ ? ĂŶĚ ďĞŚĂǀŝŽƵƌĂů ƉƌŽďůĞŵƐ ?(Robertson, 2005). It involves a ~2 Mb imprinted 
genomic region that consist of a combination of maternally and paternally imprinted genes 
(Robertson, 2005). The Angelman syndrome occurs in ~1 in 15,000 births and is 
ĐŚĂƌĂĐƚĞƌŝǌĞĚ  ?ďǇ ŵĞŶƚĂů ƌĞƚĂƌĚĂƚŝŽŶ ? ƐƉĞĞĐŚ ŝŵƉĂŝƌŵĞŶƚ ĂŶĚ ďĞŚĂǀŝŽƵƌĂů ĂďŶŽƌŵĂůŝƚŝĞƐ ?
(Robertson, 2005). The imprinting-defect is caused by the loss of maternally expression of 
the gene UBE3A, which is solely imprinted in the brain.  
 
1.4 Epigenetics and the Environment 
Although epigenetic modifications are predominantly stable, it is often discussed whether 
they might be influenced by environmental factors. Thereby, environmental influences 
ŵŝŐŚƚ ŚĂǀĞ Ă ĚŝƌĞĐƚ ĞĨĨĞĐƚ ŽŶ ĂŶ ŽƌŐĂŶŝƐŵ ?Ɛ ŐĞŶĞ ĞǆƉƌĞƐŝŽŶ ůĞǀĞů ĂŶĚ ŝƚƐ ƉŚĞŶŽƚǇƉĞ ? /Ŷ
plants, persistent temperature changes can control epigenetic modifications (Chinnusamy 
and Zhu, 2009) ? WůĂŶƚƐ ? ǀĞƌŶĂůŝǌĂƚŝŽŶmight be regulated by epigenetic transitions in the 
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following manner. In temperate climates they are initiated to flower directly after having 
been exposed to the cold temperatures of winter (D.-H. Kim et al., 2009). In detail, Kim et al. 
show that vernalization of Arabidopsis is controlled by histone modifications of flowering 
suppressor genes (D.-H. Kim et al., 2009). Environmental-based epigenetic regulation in 
plants was also observed in Linaria vulgaris with a change of the fundamental symmetry of 
the blossom from bilateral to radial (Cubas et al., 1999). Cubas et al. identified Lcyc, a 
homologue of the cycloidea gene, as the regulating gene. Flowers, exhibiting a high level of 
DNA methylation within Lcyc, involve a change of symmetry. This DNA methylation 
regulated phenomenon is highly adaptable. A demethylation of Lcyc during somatic cell 
differentiation reverses the symmetry of the flower (Cubas et al., 1999). 
Environmental-based epigenetic regulation can also be observed in mammalian organisms. 
There are different animal models, which show a correlation between environmental 
influences and changes in the epigenome (Rosenfeld, 2010). The agouti viable yellow allele 
(A
vy
) in the mouse is an example of a metastable epiallele, an allele that can stably exist in 
more than one epigenetic state, resulting in different phenotypes (Rakyan et al., 2002). The 
epigenetic state of a metastable epiallele can switch and establishment is a probabilistic 
event. Once established, the state is mitotically inherited (Rakyan et al., 2002). The 
methylation level of the intracisternal A-particle retrotransposon of the A
vy
 locus is strongly 
associated with the coat colour of the mouse. A weakly methylated retrotransposon and 
therefore expressed agouti gene leads to a yellow coat colour, obesity and diabetes 
(Morgan et al., 1999). Folate (a B vitamin, which is abundant in green vegetables and fruits), 
and further compounds that affect one-carbon-transfer reactions, interfere with the DNA 
methylation level of A
vy
 of the developing offspring. The resulting coat color distribution of 
the offspring is shifted towards the brown pseudoagouti phenotype (Morgan et al., 1999). 
However, the methylation state of the mother remains unmodified (Waterland and Jirtle, 
2003). 
In humans, it is known that nutrition, emotional stress and toxic exposure might influence 
the phenotype by epigenetic changes (Gluckman et al., 2009) (see Table 3). Especially 
gestational effects can be observed in mammalians. An experiment gives proof that 
suboptimal nutrition during elementary gestation implicates increased incidence of type 2 
diabetes in the offspring of rats (Sandovici et al., 2011). Ewes showed also adverse effects 
during gestation. The offspring of pregnant ewes, who were fed a restricted amount of 
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folate, methionine and vitamin B12, showed health problems that were caused by 
decreases in the DNA methylation levels of specific CpG islands (Sinclair et al., 2007). 
Environmental-based epigenetic regulations, based on histone modifications, have 
additionally been identified. The offspring of japanese macaques, fed high-fat diet during 
gestation, show a globally high level of acetylation of histone H3 (Aagaard-Tillery et al., 
2008). In summary, fetal metabolic impairments due to nutritional restrictions are 
associated with epigenetic alterations, which affect the risk of chronic disorders throughout 
ĂŶŽƌŐĂŶŝƐŵ ?ƐůŝĨĞƚŝŵĞ ?
 
Table 3: Environmental-induced epigenetic alterations that affect health. 
Table modified from (Robert Feil and Mario F Fraga, 2011) 
Compound Species Ontogenic 
stage 
Epigenetic 
alteration 
Tissues or cell 
types 
affected 
Phenotypic 
alterations 
References 
Tobacco 
smoke 
Human Adult life DNA 
methylation and 
histone 
modifications 
Lung, blood Lung cancer? (Pulling et al., 2004; 
Breitling et al., 2011; 
Hussain et al., 2009) 
Particulate 
air pollution 
Human, 
mouse 
Adult life DNA 
methylation 
Blood, sperm Unknown (Baccarelli et al., 2009; 
Yauk et al., 2008) 
Silica Human Adult life DNA 
methylation 
Blood Silicosis (Umemura et al., 2008) 
Benzene Human Adult life DNA 
methylation 
Blood Increased risk 
of AML 
(Bollati et al., 2007) 
 
Postnatal effects of environmentally-based epigenetic alterations can be observed as well. 
As already mentioned in the beginning of the introduction, Fraga et al. pointed out that 
monozygotic twins develop varying DNA methylation patterns during lifetime (Mario F Fraga 
et al., 2005). Moreover they showed that differences in DNA methylation correlate with 
increasing age. Some of these alterations might be explained by environmental factors.  A 
further experiment approaching the same question was done by Wong et al. in 2010 (C. C. Y. 
Wong et al., 2010). They use DNA of 46 monozygotic and 45 dizygotic twin-pairs to generate 
locus specific DNA methylation levels of the dopamine receptor 4 gene (DRD4), the 
serotonin transporter gene (SLC6A4/SERT) and the X-linked monoamine oxidase A gene 
(MAOA) at both ages 5 and 10 years. The results of their study confirmed individual 
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differences in DNA methylation patterns, which are already established in early childhood, 
whereas they additionally might be altered during lifetime (C. C. Y. Wong et al., 2010). This 
highlights the dynamic property of epigenetic modifications induced by varying life 
conditions. 
A direct association between altered global DNA methylation states and air pollution is 
given by an epidemiological study of Baccarelli et al. in 2009 (Baccarelli et al., 2009). Tissue-
specific alterations in DNA methylation of several loci were associated with environmental 
influences, such as chronic exposure to sunlight, asbestos and tobacco smoke, consumption 
of alcohol and use of hair dye (Christensen et al., 2009; Langevin et al., 2011; Grönniger et 
al., 2010). Especially the interference of tobacco smoking on DNA methylation is of great 
interest, since it has been validated that smokers and former smokers show an enrichment 
of methylated promoter regions of tumor-suppressor genes in non-transformed lung cells 
(Pulling et al., 2004). Altogether, it has been shown that toxic environmental exposure might 
bias global and locus-specific DNA methylation patterns, whereas it should be differentiated 
between directly affected tissues and indirectly affected tissues exposed to chemical 
pollutants. 
  
1.5 Transgenerational Epigenetic Inheritance 
Transgenerational epigenetic effects require epigenetic alterations in the germ line, which 
are not erased by the reprogramming mechanism in the early embryo (see section 1.2). It is 
often discussed, whether disease risk, influenced by environmental-based epigenetic 
alterations, can be inherited (see section 1.4). Most of the environmental-based epigenetic 
effects that affect the offspring can be observed during gestation (Robert Feil and Mario F 
Fraga, 2011) and cannot be attributed to a transgenerational transmission mechanism. For 
example, when a female of the F0 generation (initial parent generation in a multi-generation 
study) is exposed to toxic environmental influences, both the F1 embryo and the F2 
generation germ line are also affected by the exposure (Jirtle and Skinner, 2007). Thus, 
transgenerational environmental-based epigenetic effects have to be found in the F3 
generation. Even studies analyzing postnatal or adult transgenerational effects have to 
assess the F2 generation, since F1 generation germ line is also directly affected by parental 
exposure (Ikeda et al., 2005; Blatt et al., 2003; Barber et al., 2006). 
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Several human and animal studies based on nutritional deficiency emphasize that an F0 
exposure might influence the phenotype of the F2 generation (Pembrey et al., 2006; Csaba 
and Karabélyos, 1997; Ottinger et al., 2005; Anderson et al., 2006; Csaba and Inczefi-Gonda, 
1998; Newbold et al., 2006; Popova, 1989; Zambrano et al., 2005). Specific chemical 
exposures to the F0 generation show also effects in the F2 generation (Dubrova, 2005; Csaba 
and Inczefi-Gonda, 1998; Popova, 1989; Turusov et al., 1990). A transgenerational effect 
that is even passed to the F3 generation is caused by the endocrine disruptor vinclozolin, an 
antiandrogene (a blocker for steroid hormone that promotes male secondary sex 
characters), which causes spermatogenic defects, male infertility, breast cancer, kidney 
disease, prostate disease and immune abnormalities in up to four generations, but only 
when transmitted through the male germ line (Anway et al., 2006). Recent publications 
pointed out that these transgenerational effects were probably caused by epigenetic 
alterations (Jirtle and Skinner, 2007; Anway et al., 2005; Chang et al., 2006). 
As already indicated, most of transgenerational epigenetic studies describe effects based on 
maternal exposure during gestation (Robert Feil and Mario F Fraga, 2011) (see section 1.4). 
In 2010, Carone et al. identified transgenerational effects in metabolic gene expression of 
mice based on paternal diet (Carone et al., 2010). They combined microarray and next-
generation sequencing expression profiling analysis and MeDIP-seq (methylated DNA 
immunoprecipitation combined with next-generation sequencing) and RRBS (reduced 
representation bisulfite sequencing) to assess DNA methylation. On the transcriptional level, 
they showed that offspring of males, fed a low-protein diet, exhibit an upregulation of genes 
involved in lipid and cholesterol biosynthesis. Cholesterol ester levels were significantly 
downregulated compared to unexposed offspring. On the epigenetic level, they solely 
identified marginal alterations in liver methylomes of offspring depending on paternal diet. 
However, they indicated that a putative enhancer for a major lipid regulator, Ppara, is in 
low-protein offspring predominantly higher methylated compared to the offspring of males 
fed a control diet. 
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1.6 Thesis Structure 
The remainder of this thesis is structured as follows: 
 
Chapter 2 describes methodological considerations about NGS platforms for the 
determination of genome-wide DNA methylation patterns. Different biotechnological assays 
are discussed, whereas the main part focuses on bisulfite next-generation sequencing. 
Furthermore, primary analysis of raw sequencing data and their recommended quality 
controls are presented. Finally, secondary analyses including the alignment of bisulfite 
sequencing data are presented. All aspects considered, this chapter summarizes the 
biotechnological idea of next-generation sequencing assays, especially the one using 
bisulfite converted DNA and their bioinformatics challenges. 
 
Chapter 3 outlines findings of the dissertation, which I published as first author (the 
manuscript of Appendix C was submitted in June 2012). An application note presents a 
bioinformatics approach for the primary analysis of bisulfite next-generation sequencing 
data. An overview about recommendations and pitfalls of methylome analysis, using short 
bisulfite sequencing data on different platforms, is presented in a review article. A biological 
study about the methylome of a human B-cell lymphoma makes use of the results of the 
application note and the review mentioned above. 
 
Chapter 4 contains the discussion and conclusion of this thesis. Different bisulfite-based 
methods for genome-wide DNA methylation analysis are discussed and findings of this 
thesis are integrated ŝŶƚŽ ƚŽĚĂǇ ?Ɛ ĞƉŝŐĞŶĞƚŝĐ ƌĞƐĞĂƌĐŚ. Finally, future perspectives of 
computational epigenetics are presented. 
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For the Projects, incorporated in this thesis, next-generation sequencing (NGS) was carried 
out. The following section provides insight into different technologies and the respective 
challenges and limitations. The main part concerns bisulfite sequencing, a method for the 
determination of genome-wide DNA methylation levels at single-base resolution. Detailed 
information about the methods, used in each project, can be found in the supplement of the 
respective publication (see Chapter 3). 
 
2.1 Next-Generation Sequencing 
NGS enables the cost-efficient generation of large sequencing data sets for case-control and 
evolutionary studies based on whole genomes at single-base resolution. Today, NGS is 
especially used for variant detection by resequencing (personnel genomes), transcriptome 
analysis (RNA-seq), and the discovery of epigenetic variations (DNA methylation). Before 
NGS was established, research projects, including the generation of the human genome by 
the International Human Genome Consortium (IHGSC, 2004), were dependent on 
automated Sanger sequencing. 
The biotechnological workflow of NGS basically involves three steps: template preparation, 
sequencing or alternatively imaging, and the bioinformatics analysis including sequence 
mapping or genome assembly. The latter is specifically highlighted in section 2.3. The fast 
technological development reveals new systems within short periods of time. Selected 
methods, relevant for the projects incorporated in this thesis, are presented in this chapter. 
Two main assays are used for the preparation of templates, namely amplification-based 
methods and single molecule templates (the latter are discussed in section 4.5). For 
amplification-based template preparation, emulsion polymerase chain reaction (PCR) and 
solid-phase based methods are most often used (Dressman et al., 2003; Fedurco et al., 
2006). Emulsion PCR uses beads equipped with a primer to bind amplified single-stranded 
DNA molecules. Therefore, millions of beads are fixed in a polyacrylamide gel for the 
upcoming sequencing step. A substantial advantage of emulsion PCR is the cell-free 
environment avoiding the arbitrary loss of sequences, which is a problem in bacterial 
cloning methods (Metzker, 2010). The alternative amplification-based approach for 
template preparation, namely solid-phase amplification, fixes clusters of immediately 
adjacent primers to a solid surface in order that added single-stranded DNA molecules result 
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in bridges between their corresponding primers. The subsequent amplification takes place 
along these bridges. It has to take into account that amplification by PCR might imply biases 
as for instance transcription errors or underrepresentation of specific sequences (Acinas et 
al., 2005). 
The 454 technology by Roche was the first NGS platform established in 2005. It uses the 
emulsion PCR for the amplification step and the pyrosequencing technology (Ronaghi et al., 
1996). Pyrosequencing by the 454 approach basically involves the complementation of 
single stranded DNA and the simultaneous sensing of the signal emitted from the respective 
nucleotide (see Figure 2.1). This technology avoids electrophoresis as the decoding can be 
proceeded during the sequence extension. In detail, each nucleotide is added by a 
polymerase chain reaction and a pyrophosphate for each nucleotide is transformed to an 
ATP by an ATP sulfurylase (Metzker, 2010). Afterwards, unincorporated nucleotides are 
washed away and the same process is started for the adjacent base. The average error rate 
of the 454 method is in the range of 10
-3
-10
-4
 (Margulies et al., 2005; Quinlan et al., 2008), 
which is significantly higher than for Sanger sequencing. The error rate of the 454 approach 
increases towards the end of the underlying sequence, which is caused by a decrease of the 
productivity of the specifc enzyme resulting in weaker signals (Kircher & Kelso 2010). 
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Figure 2.1: The idea of the 454 pyrosequencing approach. 
Figure from (Metzker, 2010) 
 
The HiSeq 2000 technology of Illumina uses the solid-phase amplification. Effectively, this 
sequencing by synthesis approach is similar to the idea of Sanger sequencing. A reversible 
dye terminator is used to control the incorporation of solely one nucleotide (Metzker, 
2010). Free nucleotides are washed away and the respective integrated nucleotide is 
readout by four images using different filters and lasers to differentiate all genomic bases. 
Subsequently, dye terminators are removed and the procedure starts for the adjacent base. 
This approach exhibits a per base error rate of about 10
-2
-10
-3
, which is slightly higher 
compared to the 454 method
 
(Kircher et al., 2009; Dohm et al., 2008). The per-base error 
rate also increases towards the end of the sequence, which is mainly due to phasing (not 
synchronized amplification of a population of DNA molecules). This phenomenon 
significantly increases the background noise (Kircher & Kelso 2010). More precisely, uni-
directional phasing results in an incorrect reversible termination, which leads to an 
uncontrolled synthesis of further nucleotides (Kircher et al., 2009; Erlich et al., 2008). 
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Figure 2.2: The concept of the HiSeq 2000 approach using a reversible dye terminator. 
Figure from (Metzker, 2010) 
 
2.1.1 Two-base Encoding Sequencing 
The research projects, incorporated in this thesis, make use in particular ŽĨ ƚŚĞ ^K>ŝ ?
sequencing technology of Life Technologies (see Chapter 3). Therefore, this approach is 
comprehensively presented in the following section. ^K>ŝ ?ƐĞƋƵĞŶĐŝŶŐwas developed by 
the Harvard Medical School and the Howard Hughes Medical Institute in 2005 (Shendure et 
al., 2005). It is the third NGS platform beyond the 454 platform and the Illumina Genome 
Analyzer (the predecessor of the HiSeq 2000 platform). The fundamental difference in 
^K>ŝ ?ƐĞƋƵĞŶĐŝŶŐ, compared to those mentioned above, is the fact that it uses a ligation 
reaction instead of a polymerase reaction (Shendure et al., 2005). Hereby, 8-mer probes 
modified with four different fluorescent labels are allocated for the ligation at single-
stranded sequences hybridized with primers (LifeTechnologies, 2008). The two  ? ?-most 
nucleotides encoding the fluorophore are readout to determine the respective base. 
Subsequently, three bases including the dye ĂƌĞĐůĞĂǀĞĚĨƌŽŵƚŚĞ ? ?ĞŶĚŽĨƚŚĞ ?-mer. The 
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remaining 5-mer ƉƌŽďĞ ǁŝƚŚ Ă ĨƌĞĞ  ? ? ƉŚŽƐƉŚĂƚĞ is used for the next ligation step. On 
average, 10 ligations are concatenated and the resulting sequence is then washed away to 
start the process for the next primer set. This upcoming primer set is solely shifted one base 
ƚŽǁĂƌĚƐƚŚĞ  ? ?ĞŶĚŽĨ ƚŚĞƵŶĚĞƌůǇŝŶŐĨƌĂŐŵĞŶƚ  ?ƐĞĞFigure 2.3). Each primer exists in four 
modifications to ensure the presence of all four nucleotides in the first ligation step. 
There are various sources of erroneous base call. Firstly, the emulsion PCR amplification 
step leads to a higher error rate than solid-phase amplification methods (Kircher & Kelso 
2010). Secondly, an incomplete cleavage of the dye can result in a biased ligation process. 
The efficiency of a phosphate-based termination in this NGS approach minimizes the per 
base error rate of phasing. Altogether, the estimated per base error rate is in the range of 
10
-2
-10
-4
, which depends on the availability of a reference genome to correct errors (Kircher 
& Kelso 2010) (see Figure 2.5). 
 
 
Figure 2.3: Sequencing by ligation using a two-ďĂƐĞĞŶĐŽĚŝŶŐƚĞĐŚŶŽůŽŐǇďǇƚŚĞ^K>ŝ ?system. 
Figure from (LifeTechnologies, 2008) 
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The sequence output of two-base encoding ^K>ŝ ?sequencing is called color space. Sanger 
sequencing already encodes nucleotides by colors. However, ^K>ŝ ?ĐŽůŽr space makes use 
of 4 colors, where each encodes 4 out of 16 transitions between all nucleotides (see Figure 
2.4). 
 
 
Figure 2.4: Scheme ŽĨ^K>ŝ ?ĐŽůŽƌƐƉĂĐĞ . 
Figure from (LifeTechnologies, 2008) 
 
Hence, two independent ligation steps determine each nucleotide, which results in a higher 
specificity. This fact enables the differentiation of sequencing errors and potential variants 
such as single nucleotide polymorphisms (SNPs). In detail, a single color change within a 
^K>ŝ ? ƐĞƋƵĞŶĐĞ ŝƐ ƚǇƉŝĐĂůůǇ ƚƌĂĐĞĂďůĞ to a measurement error (LifeTechnologies, 2008). 
However, two adjacent color changes normally indicate a SNP. Furthermore, insertions and 
deletions can be detected in a similar manner (see Figure 2.5). 
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Figure 2.5: Properties of color space reads containing measurement errors and variants. 
Figure from (LifeTechnologies, 2008) 
 
2.2 Bisulfite Sequencing-based Methods to Profile DNA Methylation 
2.2.1 Bisulfite Sequencing 
Currently, there are two different approaches for the detection of DNA methylation based 
on NGS. Basically, they can be split into enrichment-based and bisulfite-based methods. 
Enrichment-based methods consist of methylated DNA immunoprecipitation sequencing 
(MeDIP-seq) and methylated DNA binding domain sequencing (MBD-seq) (Jacinto et al., 
2008; Down et al., 2008; Serre et al., 2010). MeDIP-seq makes use of an anti-methylcytosine 
antibody to immunoprecipitate single-stranded DNA fragments. MBD-seq involves an 
enrichment of double-stranded DNA fragments via the MBD2 protein methyl-CpG binding 
domain. Recent publications have shown that enrichment-based and bisulfite-based 
methods generate comparable DNA methylation results (Harris et al., 2010; Bock et al., 
2010). 
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Bisulfite sequencing (BS-seq) involves the bisulfite conversion of genomic DNA combined 
with NGS. The bisulfite treatment of DNA molecules enables a differentiation between 
methylated and unmethylated cytosines at single-base resolution. Thereby, unmethylated 
cytosines are converted to uracils, whereas methylated cytosines remain unmodified 
(Frommer et al., 1992). Uracils are read as thymines by DNA polymerase. Thus, the 
amplification of bisulfite-treated DNA by PCR yields products in which unmethylated 
cytosines appear as thymines. Consequently, differences in methylation states at single-base 
resolution can be inferred depending on the amount of cytosines and thymines assigned to 
a specific genomic position. BS-seq is nowadays the gold standard for genome-wide DNA 
methylation analysis because of its clear readout at each cytosine position. A limitation of 
BS-seq is the fact that it cannot distinguish between DNA hydroxymethylation (see section 
1.2) and usual DNA methylation. In detail, bisulfite treatment converts unmethylated and 
non-hydroxymethylated cytosines to thymines and leaves methylated and 
hydroxymethylated sites unmodified (Krueger et al., 2012). Hence, the respective 
modification cannot be determined separately. 
 
2.2.2 Reduced Representation Bisulfite Sequencing 
BS-seq is an accurate method for the determination of genome-wide DNA methylation 
levels. However, it is still a cost-intensive approach especially for large genomes. Meissner 
et al. developed a genome-scale method, which also makes use of bisulfite converted DNA, 
providing insights into parts of the methylome (Meissner et al., 2005). Their reduced 
representation bisulfite sequencing (RRBS) approach enables the facilitation of case-control 
studies involving large sample sizes (Gu et al., 2010). The idea of RRBS is to digest genomic 
DNA with a methylation-insensitive restriction enzyme. Fragments of a specific length are 
selected to filter the most informative genomic subset. Then, a bisulfite conversion of end-
repaired, A-tailed, and adapter ligated fragments is carried out to determine DNA 
methylation levels as described in section 2.2.1 (Gu et al., 2011). Hereby, DNA methylation 
patterns of parts of the genome can be obtained. It has been shown that these restricted 
fragments cover especially core promoters and CpG islands (Gu et al., 2010), which include 
essential regulatory parts of the genome. Altogether, RRBS composes only ~1% of the 
underlying whole genome (Meissner et al., 2008). It has been shown that DNA amounts of 
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10- ? ? ?ɻŐare sufficient to generate accurate DNA methylation levels with RRBS (Gu et al., 
2011). Consequently, it is well-suited for many clinical samples, such as tumors, which can 
only provide a small amount of genomic input DNA material. 
The following section describes selected steps of the preparation of a RRBS library using the 
digestion enzyme MspI (see Figure 2.6). Further bisulfite-based library preparation protocols 
are given in the respective supplemental information of projects incorporated in this thesis 
(see Chapter 3). 
 
 
Figure 2.6 Workflow of a RRBS library preparation. 
Figure modified from (Gu et al., 2011) 
 
x Isolation of genomic DNA: It is mandatory to use highly purified genomic input DNA to 
generate a high-quality RRBS library (Gu et al., 2011). Contaminated DNA molecules 
might interact with restriction enzymes and interfere with the bisulfite conversion. Gu et 
al. additionally recommend the use of DNase-free RNase in the lysis buffer to avoid DNA 
degradation (Gu et al., 2011). 
x Digestion reaction: Two different enzymes are commercially available by now: MspI 
(restriction ŵŽƚŝĨ ?A?CGG) and TaqI (restriction ŵŽƚŝĨ ?dA?' ?(Gu et al., 2011). Both, 
MspI and TaqI are insensitive for CpG DNA methylation, whereas MspI exclusively 
generates fragments containing CpG dinucleotides at both ends. A drawback of MspI is 
that a methylated cytosine at the first position of the restriction motif CA?CGG interferes 
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with the digestion reaction (Gu et al., 2011). However, this situation can rarely be 
observed, at least in human methylomes, since methylated non-CpG sites hardly ever 
occur (Pelizzola and Ecker, 2010) (see section 1.2.2). 
x Filling in and A-tailing:  ? ?-terminal recessive ends containing an adenine are added, 
since they are required for the adapter ligation of the upcoming library preparation (Gu 
et al., 2011). 
x Methylated adapter ligation: Both, single-end and paired-end sequencing can be carried 
out with RRBS libraries, whereas adapters have to consist of methylated cytosines to 
maintain their compatibility with the subsequent bisulfite conversion. Paired-end 
sequencing certainly has the advantage to increase the mapping efficiency by unique 
alignments. However, it can also bias DNA methylation levels, as overlapping pairs 
generate redundant DNA methylation information (Krueger et al., 2012). 
x Gel size selection: Before fragments are bisulfite converted, they are size selected. In-
silico analyses show that a size selection of 40-220 bp for fragments, containing the MspI 
restriction ŵŽƚŝĨљ'', covers most promoter sequences and CpG islands (Gu et al., 
2011). 
x Bisulfite conversion, PCR amplification, and sequencing: Digested and size-selected 
fragments are finally bisulfite converted. In the end, fragments are amplified by PCR for 
the sequencing process on a NGS platform. To date, RRBS is solely carried out on 
Illumina platforms. 
 
The bioinformatics challenge of analyzing RRBS sequencing data is given by the fact that the 
alignment step requires an in-silico modified reference genome. Thus, the reference should 
consist of size-selected and enzyme specific digested genomic sequences. Apart from the 
alignment reference, RRBS depends on comparable bioinformatics primary and secondary 
analyses as they are applied to genome-wide BS-seq. Details about challenges and pitfalls of 
BS-seq data are given in section 2.3.1 and 2.3.2.  
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2.3 Analysis of Bisulfite Sequencing Data 
2.3.1 Quality Control 
Several quality control approaches for BS-seq data exist. Firstly, sequencing results can be 
validated by positive and negative controls incorporated into the sequencing library. 
Secondly, raw sequencing data can be controlled for quality by in-silico analyses to filter 
contaminations. 
An effective quality control can be performed with lambda phage (enterobacteria phage) 
DNA, which is spiked-in during the library preparation. The lambda phage genome is 
originally completely unmethylated and is therefore used as a positive control of the 
bisulfite conversion. Hence, the overall DNA methylation level in the lambda phage genome 
assesses the quality of the bisulfite conversion. Recent publications identified 1% of 
methylated cytosines within the lambda phage genome (Lister et al., 2009, 2011; Hansen et 
al., 2011). 
A critical part of genome-wide DNA methylation analyses is the determination of non-CpG 
sites. As already mentioned in section 1.2.1, ES cells involve the highest amount of 
methylated non-CpG sites in human cells. However, the principal part of these non-CpG 
sites involves DNA methylation levels of less than 0.4 (Lister et al., 2009). Hence, it is 
indispensable to distinguish between truly low methylated non-CpG sites and non-CpG sites, 
which involve a low DNA methylation due to an incomplete or defective bisulfite conversion. 
Considering that, Lister et al. developed the following approach using an estimation of the 
bisulfite conversion based on the lambda phage. They used the binomial distribution: 
 ݂ሺ݇Ǣ ݊ǡ ݌ሻ ൌ ቀ݊݇ቁ ݌௞ሺ ? െ ݌ሻ௡ି௞???? ? ൑ ݇ ൑ ݊??? ቀ݊݇ቁ ൌ ݊Ǩ݇Ǩ ሺ݊ െ ݇ሻǨ 
  
Parameters are defined as follows: n is the sequence coverage at a specific genomic 
position; k is the number of sequenced cytosines at the corresponding genomic position; p is 
the fraction of cytosines sequenced in the lambda genome and the sum of all thymines and 
cytosines sequenced in the lambda genome i.e. the genome-wide fraction of DNA 
methylation in the lambda phage genome. The result of this binomial distribution is the 
probability that the DNA methylation level of a specific cytosine arises from an incomplete 
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bisulfite conversion. In summary, this method enables a quality control for the bisulfite 
conversion, which then can be used for the classification of all DNA methylation levels. 
In the following section examples of bioinformatics quality controls are presented to 
validate bisulfite sequences obtained from NGS platforms. Detailed information about 
bioinformatics quality control of bisulfite sequencing data can be found in the publication 
incorporated as Appendix B. The following analyses are based on the publicly available tools 
FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and Trim Galore 
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/). 
Firstly, it is mandatory to visualize the distribution of quality scores at each position in 
bisulfite sequences with FastQC. Low base call qualities, which most often arise towards the 
end of sequences, can be eliminated with Trim Galore. Therefore partial sums from all 
positions of the bisulfite sequence to its end are computed. The bisulfite sequence is 
truncated at the position involving the minimal relative partial sum. Thus, low base call 
qualities, which frequently involve false positive base-calls, are reduced. It has been shown 
that this quality control results in more precise DNA methylation levels (see supplemental 
information of Appendix B). 
Furthermore, it is recommended to control genome-wide frequencies of all four nucleotides 
at each position in bisulfite sequences. These frequencies are shifted for bisulfite sequences 
compared to usual genomic sequences due to the conversion of unmethylated cytosines to 
thymines. For the human genome, 67-82% of all CpG sites are methylated, whereas not 
more than 3% of all non-CpG sites are methylated. However, only 5% of all cytosines are 
located in CpG dinucleotides resulting in approximately 96% of unmethylated cytosines in 
the human genome. These unmethylated cytosines appear as thymines after the bisulfite 
conversion and the PCR (Pelizzola and Ecker, 2010). Thus, the percentage of cytosines is to 
the greatest extent very low, whilst the amount of thymines is cleary enriched. The analysis 
and adjustment of these frequencies can be performed with FastQC and Trim Galore (see 
supplemental information of Appendix B). 
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2.3.2 Mapping of Bisulfite Sequencing Data 
The mapping of sequences generated by BS-seq poses the main challenge for this type of 
data. Mapping approaches for usual genomic sequencing combine the alignment to the 
Watson and its complementary Crick strand. However, bisulfite conversion of DNA 
sequences results in non-complementary strands. In detail, there are up to four distinct 
strands, which have to be included in the mapping reference (see Figure 2.7). This situation 
can be avoided by a specific library preparation, which predetermines the ligation of 
adapter sequences before the PCR amplification is carried out. In this case, only two distinct 
bisulfite treated strands are sequenced. This type of BS-seq library is called a directional BS-
seq library, whilst a BS-seq library involving all four strands is called a non-directional BS-seq 
library (Krueger and Andrews, 2011). Further observations are based on BS-seq data 
obtained by directional libraries. In conclusion, the mapping of BS-seq data needs to be 
performed for the reference and additionally for its in-silico bisulfite converted 
modifications (see Appendix B). 
 
 
Figure 2.7: Impact of bisulfite conversion on double stranded DNA sequences. 
 
 
 
Watson >>GACCmGATTCCAGTCmGG>> Cm methylated
Crick <<CTGGCmTAAGGTCAGCmC<< C unmethylated
Watson >>GACCmGATTCCAGTCmGG>> Crick <<CTGGCmTAAGGTCAGCmC<<
BS-Watson >>GAUCmGATTUUAGTCmGG>> BS-Crick <<UTGGCmTAAGGTUAGCmU<<
BS-Watson >>GATCmGATTTTAGTCmGG>>
RCBSW <<CTAG CTAAAA TCAG  CC<<
BS-Crick <<TTGGCmTAAGGTTAGCmT<<
RCBSC >>AACCG ATT CC AATCG  A>>
Denaturation
Bisulfite conversion
PCR amplification
RCBSW: Reverse complement of BS-Watson RCBSC: Reverse complement of BS-Crick
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A further limitation of bisulfite sequences is the fact that their complexity is significantly 
reduced. About 96% of all cytosines in human methylomes are unmethylated and by this all 
of these cytosines appear as thymines in bisulfite sequences. Consequently, bisulfite 
sequences predominantly consist of three nucleotides: adenines, guanines, and thymines. 
Therefore, resulting sequences are less differentiated and involve an increased frequency of 
ambiguous mapping results. BS-seq mapping approaches additionally have to take into 
account that thymines in bisulfite sequences might be assigned to referential cytosines and 
thymines, since they might be unmethylated cytosines or original genomic thymines (see 
Figure 2.8). 
A detailed comparison of bioinformatics tools for the mapping of BS-seq data is described in 
Appendix B. 
 
 
Figure 2.8: Mapping asymmetry of bisulfite sequences. 
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This thesis comprises a bioinformatics tool for the analysis of two-base encoding BS-seq 
data, a review about pitfalls and challenges of BS-seq analyses on different NGS platforms, 
and a biological study about a methylome of a B-cell lymphoma. 
 
3.1 Application Note (see Appendix A) 
BS-seq is currently the gold standard for the analysis of DNA methylation at single-base 
resolution. Originally, it was used on the Genome Analyzer platform of Illumina (Lister et al., 
2009). One of the main challenges within the framework of this thesis was the development 
of a bioinformatic tool for bisulfite sequencing analysis on the ^K>ŝ ? ƉůĂƚĨŽƌŵ ŽĨ >ŝĨĞ
Technologies (see section 2.1.1). In the application note, I presented B-SOLANA, the first 
tool for the analyƐŝƐ ŽĨ ůĂƌŐĞ ^K>ŝ ? ^ -seq data sets. It includes the alignment and 
determination of DNA methylation levels in CpG as well as non-CpG sequence contexts. B-
SOLANA exhibited a high alignment efficiency compared to further approaches, which are 
available by now. 
 
3.2 Review (see Appendix B) 
BS-seq is a rapidly developing research field in the last few years. In this review article, 
bioinformatics aspects about BS-seq analyses were discussed. Therefore, challenges of BS-
seq alignment as they apply to both base and color-space data were summarized. There are 
different contaminations within raw sequences, which might interfere with genome-wide 
DNA methylation levels. Potential sources of contaminations are for instance platform-
specific sequencing errors and adapter sequences. This review article presented quality 
controls of BS-seq data and methods to minimize false positively detected DNA methylation 
levels. Finally, it gives a recommendation of the most appropriate way to analyze this type 
of data.  
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3.3 Study (see Appendix C) 
This study analyzed the methylome of the DAUDI cell line, an archetypal endemic Burkitt ?Ɛ 
lymphoma. It combined genome-wide DNA methylation results obtained by BS-seq on the 
HiSeq 2000 and the ^K>ŝ ? ƉůĂƚĨŽƌŵ, whereas platform-independent data sets exhibited 
comparable results. DNA methylation levels of 91.1% of all referenced CpG sites and 90.2% 
of all referenced non-CpG sites of the DAUDI methylome were assessed. The genome-wide 
DNA methylation accounted for 68.99%, which is comparable to further human methylomes 
(Li et al., 2010; Lister et al., 2009). The study identified an enrichment of significantly 
methylated non-CpG sites within RefSeq genes, which was previously reported for the 
methylome of the ES cell line H1 (Lister et al., 2009). Correlation analysis revealed that 
transcription levels were strongly associated with the amount of methylated CpG sites 
around the transcription start site (TSS), where present transcripts involved CpG sites with 
minimal DNA methylation levels immediately at the TSS. Interestingly, sharp transitions of 
DNA methylation levels at exon-intron boundaries of absent transcripts could be identified. 
It was previously shown that DAUDI involves an upregulation of the Epstein-Barr virus (EBV) 
(D. N. Kim et al., 2011). In our study, the EBV and the mitochondrial methylome and their 
transcriptomes were analyzed, which showed that methylation in CpG dinucleotides 
significantly varied between nuclear (68.99%), mitochondrial (6.43%) and EBV (80.18%) 
genomes. In conclusion, the analysis revealed that the mechanisms of DNA methylation 
associated with transcriptional regulation in ĞŶĚĞŵŝĐƵƌŬŝƚƚ ?Ɛlymphomas go by far beyond 
the usually studied promoter methylation. 
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The first part of this chapter integrates the results of this thesis into the current state of 
knowledge concerning DNA methylation analyses. The development from array-based to 
NGS-based DNA methylation analyses is described and different NGS-based methods, 
involving computational approaches for the determination of interindividual DNA 
methylation differences, are compared. The second part of this chapter comprises 
conclusions drawn from this thesis and discusses future perspectives of computational 
epigenetic studies. The following observations are based on analyses of DNA methylation in 
human genomes. 
4.1 From Array Technologies to Next-Generation Sequencing 
In the past, most epigenetic studies examined DNA methylation patterns within promoter 
regions to identify regulatory effects related to gene expression. Advantages and 
disadvantages of array-based and NGS-based methods are presented in the following 
section. 
In the following comparison, the Infinium HumanMethylation BeadChip of Illumina, an array 
method based on bisulfite converted DNA, is discussed. The current version assesses DNA 
methylation levels of about 485,000 CpG sites. It covers 99% of RefSeq genes, with an 
average of 17 CpG sites within the promoter, the ?? untranslated region, the first exon, the 
gene body, and the ?? untranslated region. Additionally, DNA methylation in 96% of all CpG 
islands, with additional coverage in island shores is assessed. DNA methylation levels are 
quantified by beta values. Beta values range from 0 (low DNA methylation level) to 1 (high 
DNA methylation level). This technology is a hybrid approach of two different chemical 
assays, the Infinium I and Infinium II assays. The previous version of the HumanMethylation 
BeadChip array, assessing only 27,000 CpG sites, used the Infinium I assay. However, one 
third of the DNA methylation levels measured by the current version are obtained by the 
Infinium II assay, whereas recent publications indicated that this chemical assay is less 
accurate and reproducible (Sandoval et al., 2011; Bibikova et al., 2011; Dedeurwaerder et 
al., 2011). It is mandatory to correct the Infinium II results to obtain comparable DNA 
methylation levels assessed by both chemical assays. Varying bioinformatics approaches are 
available for this task by now (Dedeurwaerder et al., 2011). 
The choice of DNA methylation profiling technology certainly depends on which problem is 
studied. Whole genome DNA methylation analyses usually use sequencing-based methods. 
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However, gene-specific studies apply either array-based approaches or even candidate 
gene-specific methods, where the latter can be carried out with bisulfite Sanger sequencing. 
Genome-wide arrays, as described above, are a reliable and cost-efficient tool for the 
determination of quantitative DNA methylation levels at specific genomic loci. However, 
they should rather be used for large studies than for the measurement of different DNA 
methylation patterns between few samples. The relatively low density of array-annotated 
cytosines within a specific genomic domain implies a weak statistical power for the 
detection of DMRs. Even a small number of varying DNA methylation levels, potentially 
induced by technological biases, significantly influence test statistics (see section 4.2). 
Independent comparisons between array-based and NGS-based methods indicated 
comparable results (Kreck et al., 2011; Bock et al., 2010) (see Appendix A). However, 
extreme DNA methylation levels are assessed differently (see supplemental information of 
Appendix A). For NGS-based methods, completely unmethylated and fully methylated sites 
correspond to DNA methylation levels of 0 and 1. The HumanMethylation BeadChip method 
merely assigns these extreme sites to DNA methylation levels close to 0 and 1. The following 
correlation analyseƐŽĨĂ^K>ŝ ?^-seq data set, consisting of cytosines covered by at least 
10 bisulfite sequences, and DNA methylation levels assessed by the HumanMethylation 
BeadChip method target this phenomenon (the data belongs to the study of Appendix A 
(see Figure 4.1). Correlation analysis were carried out using residuals i.e. differences of DNA 
methylation levels ((Methylation level)^K>ŝ ? - (Methylation level)BeadChip) assessed by both 
platforms. Both methods assess DNA methylation levels in a similar way, because most of 
the residuals are located next to 0. Nevertheless, the distribution of residuals exhibits two 
maxima next to 0 (see Figure 4.1). The left peak represents completely unmethylated sites, 
ǁŚŝĐŚ ĂƌĞ ĂƐƐŝŐŶĞĚ ƚŽ  ? ďǇ ^K>ŝ ? BS-seq and to beta values close to 0 by the 
HumanMethylation BeadChip. The right peak depicts the reverse effect of fully methylated 
sites assessed by both methods. In conclusion, this technology-specific fact has to be taken 
into account for the determination of weakly differentially methylated sites of extreme DNA 
methylation levels. 
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Figure 4.1 ?ZĞƐŝĚƵĂůƐŽĨEŵĞƚŚǇůĂƚŝŽŶůĞǀĞůƐĂƐƐĞƐƐĞĚďǇK^>ŝ ?^-seq and the HumanMethylation 
BeadChip. 
 
Correlation analyses of DNA methylation vs. transcriptional levels are preferably carried out 
for regions upstream of genes and especially promoters. Array-based methods assess 
specific representative cytosines within these genomic regions. However, Appendix C 
pointed out that it is necessary to consider the majority of cytosines around the TSS to 
receive precise results of the correlation analyses. High transcriptional levels correlate with 
minimal DNA methylation at the TSS, which then rapidly increases towards downstream and 
upstream directions (see Appendix C). Thus, array-based methods only enable an insight 
into DNA methylation levels and are less conclusive concerning correlation analyses related 
to transcriptional levels. 
In the human genome, 67-82% of all cytosines within CpG dinucleotides are methylated 
(Pelizzola and Ecker, 2010). Cytosines within CpG dinucleotides are common sites of 
polymorphisms due to the deamination of methylated cytosines to thymines during 
evolution (Venter et al., 2001). This fact might interfere with the extraction of DNA 
methylation levels by bisulfite-based methods, since unmethylated cytosines appear as 
thymines in bisulfite converted DNA. The array-based Infinium HumanMethylation BeadChip 
technology cannot distinguish, whether variations are a result of deamination or bisulfite 
conversion (Byun et al., 2009). For this purpose, non-bisulfite converted genomic DNA has 
to be sequenced to detect potential polymorphisms. In contrast, NGS-based methods are 
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able to differentiate these two types of variations in the following way: A polymorphism 
generated by deamination of a methylated cytosine to thymine now has an adenine 
nucleotide on the opposite strand. However, the conversion of cytosines to thymines, 
induced by bisulfite treatment, leaves the guanine on the complementary strand 
unmodified. As bisulfite sequences need to be independently mapped to the forward and 
reverse strand, polymorphisms and variations, caused by bisulfite conversion can be 
independently detected. 
 
4.2 Epigenome-wide Association Studies 
Although genome-wide association studies (GWASs) identified more than 1,449 genomic 
loci that were associated to 237 diseases and traits so far, only a small proportion of the 
underlying genetic architecture can be explained (Hindorff LA, MacArthur J (European 
Bioinformatics Institute), Wise A, Junkins HA, Hall PN, Klemm AK, and Manolio TA. A Catalog 
of Published Genome-Wide Association Studies. Available at: www.genome.gov/gwastudies. 
Accessed [June, 2012]). With the establishment of NGS technologies, resequencing of 
genomes and exomes (the entirety of exons) is expected to reveal further genetic 
alterations, which might help to ĞǆƉůĂŝŶ ƚŚĞ  ?ŵŝƐƐŝŶŐ ? ŚĞƌŝƚĂďŝůŝƚǇ(Manolio et al., 2009). 
However, increasing evidence points to epigenetic factors, especially to DNA methylation, 
which might influence the pathogenesis of complex diseases (Andrew P Feinberg and 
Irizarry, 2010; Petronis, 2010; Kulis and Manel Esteller, 2010). Most studies about DNA 
methylation so far have been carried out for either a few samples with high coverage, 
generated by NGS, or for many samples with low genome-wide coverage, generated by 
array methods. The recent biotechnological development increasingly enables large-scale 
DNA methylation analyses, so called epigenome-wide association studies (EWASs). 
Chips used for GWASs allow genotyping of hundreds of thousands SNPs (Manolio et al., 
2009). Statistical approaches subsequently test the genome-wide significance of individual 
SNPs. Comparable DNA methylation chips, as for instance the current HumanMethylation 
BeadChip, measuring DNA methylation of ~485,000 sites, are available by now. However, it 
is most often insufficient to compare DNA methylation levels of single sites. Potential 
variations in EWASs are: DMRs, variably methylated regions (VMRs), allele-specific DNA 
methylation (ASM), and haplotype-specific DNA methylation (HSM). VMRs are genomic 
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regions involving moderate alteration in DNA methylation, hence an attenuated type of 
DMRs. ASMs are genomic regions exhibiting variation in DNA methylation in a parent-of-
origin specific manner or based on a nearby SNP. HSMs are DMRs defined by a combination 
of alleles within a genomic domain. These different types of epigenetic variation, involving 
single sites and even genomic regions, show the variability of distinguishing marks of DNA 
methylation. In summary, EWASs pose further challenges compared to GWASs. 
DNA methylation is a highly dynamic epigenetic modification, which might change during 
lifetime and be altered by environmental influences or drug interventions (see section 1.4). 
Furthermore, it has been shown that genetic factors can considerably influence DNA 
methylation (Zhang et al., 2010; Kerkel et al., 2008; Hellman and Chess, 2010; Shoemaker et 
al., 2010). These observations have to be considered for the design and analysis of EWASs. A 
potential approach can be the integration of already existing GWASs results in upcoming 
EWASs to control the influence of genotypes on DNA methylation variation. In the end, a 
fundamental question of DNA methylation studies is: Is DNA methylation the cause or the 
consequence of a disease or even the consequence of a genotype causing the disease? So 
far, no study exists that specifies variation in DNA methylation as the cause of the disease 
(Rakyan et al., 2011)(S. Baylin and T. H. Bestor, 2002).  
GWASs typically involve case-control studies consisting of unrelated individuals, who are 
clustered based on their phenotype. However, a potential study design of EWASs includes 
parent-offspring pairs, where combined genetic and DNA methylation analysis helps to 
identify truly associated variations in DNA methylation by filtering family-based genetic 
variations, which might alter DNA methylation (Rakyan et al., 2011). This can be achieved by 
either results of combined GWASs and EWASs or by methods, which simultaneously 
determine genetic and DNA methylation variations. A further possibility to minimize genetic 
confounders is to study monozygotic twins who are discordant for a disease. This study 
design of EWASs can be used to exclude any DNA methylation variations, which were 
caused by germline genetic variations (Kaminsky et al., 2009; Bell and Spector, 2011). Even 
this type of EWASs cannot decides whether alterations in DNA methylation are a cause or 
consequence of a specific disease. Besides confounding by genetic-epigenetic interaction, 
the high ĚǇŶĂŵŝĐ ŽĨ E ŵĞƚŚǇůĂƚŝŽŶ ? ƚŚƌŽƵŐŚŽƵƚ ĂŶ ŽƌŐĂŶŝƐŵ ?Ɛůifetime, influences the 
outcome of EWASs. Longitudinal EWASs address this key aspect considering disease-free 
people (ideally from birth) over the course of many years. In conclusion, probably the best-
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suited EWAS design, even though accompanied by great cost, is a longitudinal study of 
disease-discordant monozygotic twins, which integrates genetic-epigenetic interactions and 
environmental factors influencing DNA methylation. 
Altogether, EWASs have the potential to explain parts of the genetic architecture of diseases 
and traits, even though the study design needs to consider several confounding factors to 
decide, whether DNA methylation is a cause or a consequence of a disease. In GWASs, tags 
SNPs based on high linkage disequilibrium are often utilized for comprehensive variation 
coverage. Such sites need to be explored for EWASs to facilitate cost-efficient studies. 
However, only whole methylomes of embryonic stem cells, fetal fibroblasts, peripheral 
blood mononuclear cells, colon cancer cells and B-cell lymphomas are available by now 
(Lister et al., 2009, 2011; Li et al., 2010; Hansen et al., 2011) (see Appendix C). Thus, it is 
necessary to analyze further methylomes to identify appropriate DNA methylation sites or 
even genomic domains, which can be used for comprehensive array-based EWASs. 
 
4.3 Comparison of Sequencing-Based DNA Methylation Methods 
Different NGS-based methods for the determination of genome-wide DNA methylation are 
available by now (Bock et al., 2010; Harris et al., 2010) (see section 2.2). The four most 
commonly used sequencing-based methods are BS-seq, RRBS, MeDIP-seq, and MBD-seq. BS-
seq and RRBS enable an insight into DNA methylation at single-base resolution, whereas the 
enrichment-based methods, MeDIP-seq and MBD-seq, assess DNA methylation of genomic 
fragments ranging between 400-700 bp, which then are representative for all cytosines 
within the respective fragment (Down et al., 2008). All of these four methods exhibit 
comparable DNA methylation levels, but differ in their coverage, accuracy and cost (Bock et 
al., 2010; Harris et al., 2010). It has been shown that low sequencing coverage is most often 
sufficient to determine large differentially methylated domains or even global DNA 
methylation tendencies, but insufficient to detect loci-specific alterations. Depending on the 
problem, it is necessary to either sequence few samples more deeply or more samples less 
deeply. 
In the following section advantages and disadvantages of different sequencing-based 
methods are specified. The ability of BS-seq to assess DNA methylation at single-base 
resolution certainly results in a high accuracy and enables the simultaneous readout of 
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further variants, such as SNPs (see Appendix C). However, a substantial increase of BS-seq 
coverage is accompanied by much higher costs compared to RRBS, MeDIP-seq, and MBD-
seq. Enrichment-based methods benefitis from the fact that all four nucleotides are 
unmodified, which modestly increases the mapping efficiency compared to bisulfite-based 
methods, which predominantly involve adenines, guanines, and thymines in their bisulfite 
sequences. A further advantage of enrichment-based methods is the ability to determine 
DNA hydroxymethylation, the oxidation of methylated cytosines by the TET family (see 
section 1.2). Hydroymethylation cannot be detected by bisulfite-based methods (Krueger et 
al., 2012) (see section 2.2.1). 
Although most studies analyzed CpG methylation so far, the interest in non-CpG 
methylation increases (Lister et al., 2009, 2011; Pelizzola and Ecker, 2010). This type of DNA 
methylation can be easily detected by bisulfite-based methods. However, enrichment-based 
methods generate several difficulties. It is a challenge to separate the level of CpG and non-
CpG methylation because only entire genomic fragments are assessed. Furthermore, Lister 
et al. showed that methylated non-CpG sites are predominantly present in genomic regions 
with high CpG methylation. This fact additionally complicates the independent 
measurement of DNA methylation in different sequence contexts (Lister et al., 2009). 
In the following section, I compare RRBS and BS-seq. TŚĞ^K>ŝ ?^ -seq data set generated 
for the study of Appendix C and a RRBS data set obtained from the same cell line are 
analyzed. 79.9 gigabases (Gb) of ^K>ŝ ? sequences and 5.8 Gb of HiSeq 2000 sequences 
were aligned to the human reference (hg19/NCBI 37). The log-scaled distribution of CpG 
coverage, assessed by both methods, is depicted in Figure 4.2. Obviously, the restriction of 
RRBS to genomic regions with high density of CpG dinucleotides results in considerably 
higher coverage. By absolute numbers, the mean coverage of RRBS accounts for 59.6? and 
16.5? for SOLiD ?^ -seq. 
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Figure 4.2 ?ŝƐƚƌŝďƵƚŝŽŶŽĨĐŽǀĞƌĂŐĞŽĨƉ'ƐŝƚĞƐĂƐƐĞƐƐĞĚďǇ^K>ŝ ?^-seq and RRBS. 
 
It was previously shown that the accuracy of DNA methylation calls strongly depends on the 
coverage (Harris et al., 2010; Bock et al., 2010). This dependency was also analyzed for the 
ZZ^ ĂŶĚ ^K>ŝ ? ^-seq data sets discussed above. For the analysis, different groups of 
CpG sites, with increasing coverage, were generated. The Pearson correlation coefficient 
was used to compare DNA methylation levels of both methods (see Table 4). CpG sites, 
assessed by at least 5 bisulfite sequences, exhibit a Pearson correlation coefficient of 
r=0.902, which is in line with results of Bock et al. (Bock et al., 2010). Increasing coverage 
significantly results in higher correlations up to the threshold of 25 bisulfite sequences. 
Beyond that, coverage-specific variances are observed for single cytosines, but not for 
genomic domains. In the end, whole genome approaches, such as RRBS and BS-seq, should 
rather be used for the determination of DMRs than for DNA methylation alterations of 
single cytosines. For site-specific DNA methylation analysis, I would recommend genome-
wide arrays, such as the Infinium HumanMethylation BeadChip. 
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Table 4: Pearson correlation of RRBS and SOLiD ?^ -seq based on increasing coverage. 
Coverage ?5 ?7 ?9 ?11 ?13 ?15 ?17 
Pearson r 0.902 0.908 0.912 0.915 0.918 0.920 0.922 
Coverage ш19 ш21 ш23 ш25 ш30 ш40 ш50 
Pearson r 0.924 0.925 0.927 0.928 0.930 0.935 0.938 
 
Comprehensive analyses about platform-specific advantages and disadvantages are not 
published up to today. This issue is discussed in the remainder of this section. To date, 
bisulfite-based methods were carried out on the Genome Analyzer and HiSeq 2000 
platforms (Illumina) ?ƚŚĞ^K>ŝ ?ƉůĂƚĨŽƌŵ (Life Technologies), and the 454 platform (Roche) 
(for details about NGS platforms see sections 2.1) (Lister et al., 2009; Kreck et al., 2011; 
Bormann Chung et al., 2010; Herrmann et al., 2011). Enrichment-based methods were only 
carried out on the Genome Analyzer and HiSeq 2000 platform (Illumina) (Bock et al., 2010).  
We showed that both BS-ƐĞƋ ĚĂƚĂ ŽĨ ƚŚĞ ^K>ŝ ? ĂŶĚ ƚŚĞ ,ŝ^ĞƋ  ? ? ? ? ƉůĂƚĨŽƌŵ exhibit 
accurate and comparable CpG methylation measurements (Pearson correlation coefficient 
r=0.86) (see Appendix C). However, non-CpG methylation levels exhibit slightly different 
results. Non-CpG sites ? ĂƐƐĞƐƐĞĚ ďǇ ^K>ŝ ? -^seq, were slightly weaker methylated 
compared to DNA methylation levels of the HiSeq 2000 platform (non-CpG mean 
methylation^K>ŝ ?=0.16, non-CpG mean methylationHiSeq 2000=0.47). This fact could also be 
observed for the same non-CpG sites assessed by RRBS, even though not to this extent (non-
CpG mean methylationRRBS=0.21). However, the latter observation may be related to the 
relatively low coverage of the HiSeq 2000 data set compared to the RRBS data set. In 
summary, both platforms are applicable to generate accurate DNA methylation 
measurements, whereas organisms with a high amount of methylated non-CpG sites should 
rather be analyzed by the HiSeq 2000 platform. 
 
4.4 Interindividual DNA Methylation Differences 
Epigenetic studies particularly aim to associate epigenetic alterations with specific 
phenotypes. In the case of DNA methylation, this is usually performed by the determination 
of DMRs. Sensitivity and specificity of approaches for the determination of DMRs notably 
vary between different technologies. Array-based methods only assess selected sites. The 
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low density of covered sites might significantly decrease the statistical power (see section 
4.1). Thus DMRs obtained by array-based analysis have to be considered cautiously (see 
section 4.2). NGS-based methods provide an extensive insight into DNA methylation. 
However, there are fundamentally different computational approaches for the 
determination of DMRs in NGS data. Below, selected approaches are discussed. 
Lister et al. at first published DMRs of methylomes of ES cells H1 and fetal fibroblasts IMR90 
(Lister et al., 2009). They used a binomial distribution to determine DNA methylation sites in 
both CpG and non-CpG sequence contexts (see section 2.3.1). However, differentially 
methylated cytosines were solely determined for CpG sites, since hardly any significantly 
methylated non-CpG sites could be identified for IMR90. To exclude coverage biases, they 
compare only CpG sites of H1 and IMR90 that involve a ratio of coverage between 0.8 and 
1.2. Subsequently, Lister et al. applied a two-tailed FiƐŚĞƌ ?ƐǆĂĐƚdĞƐƚresulting in 6,023,738 
CpG sites that were more highly methylated in H1 compared to IMR90, and 124,161 CpG 
sites that were more highly methylated in IMR90 compared to H1. Finally, they used a 
sliding window approach to select 1,000 bp regions containing at least 4 differential 
methylated sites. Adjacent differentially methylated regions were joined together. 
A further publication by Lister et al. identified DMRs in iPSCs and ES cells (Lister et al., 2011). 
DMRs were detected based on more stringent test parameters than in their analysis of H1 
and IMR90 (Lister et al., 2009). They generated smoothed DNA methylation levels in 100 bp 
windows, whereas regions comprising a set of 10 adjacent windows over a distance less 
than 1,100 bp were considered. A non-parametric Wilcoxon Test (or Kruskal-Wallis Test for 
more than two samples, p<0.01) for regions involving a 4-fold enrichment of DNA 
methylation level was applied. 
Li et al. analyzed the methylome of human peripheral blood mononuclear cells (PBMCs) and 
compared it to the methylome of fetal fibroblasts IMR90 (Li et al., 2010). They used a sliding 
window approach combined with a Fisher Exact Test (p<1e
-20
). Windows should at least 
contain 5 CpG sites with a 2-fold change in DNA methylation level. They additionally 
required that both tissues do not involve DNA methylation levels of less than 0.2. Adjacent 
differentially methylation regions were as well joined together. 
Hansen et al. described methylomes of different cancer types, including colon, lung, breast, 
thyroid, and Wilms tumors (Hansen et al., 2011). They developed a bioinformatics approach 
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to smooth CpG methylation levels by their coverage and environmental CpG density. DMRs 
were determined using t statistics. 
Although it is known that different tissues and cell types involve varying methylomes, the 
respective computational method significantly influences the amount of DMRs. The 
numbers of DMRs for the methylome analyses range from 1,175 (ES cells and 5 iPSCs) (Lister 
et al., 2011) to 240,856 (PBMCs and IMR90) (Li et al., 2010). In summary, it is a challenge to 
strike a balance between methods detecting too many false positive DMRs and those, which 
miss too many DMRs. 
I developed a new sliding window approach for the determination of DMRs using smoothed 
DNA methylation levels considering environmental CpG density. Genomic windows 
containing at least 10 CpG sites within 1100 bp and 4-fold enrichment of mean DNA 
methylation levels are considered. CpG sites are then smoothed by a local polynomial 
regression fitting using the statistical software R (http://cran.r-project.org/). I use t statistics 
(p<0.01), since the Wilcoxon Rank-Sum Test is derived on the assumption that data consist 
of no ties. This assumption cannot be ensured a priori, as DNA methylation is usually 
bimodally distributed with a majority of clustered fully methylated sites (Pelizzola and Ecker, 
2010). 
For testing purposes of this DMR determination approach, methylome data of the DAUDI 
cell line (malignant B lymphocytes) and of PBMCs involving lymphocytes, monocytes, and 
macrophages were used (Li et al., 2010) (see Appendix C) (see Figure 4.3). 666 DMRs were 
identified, whereas the majority of DMRs involved higher DNA methylation in DAUDI 
compared to PBMCs (indicated as red boxes in the ideogram) and only 2 regions show a 
reverse effect (blue box in ideogram). DMRs were illustrated by a ideogram (the ideogram 
was generated with ideographica (Kin and Ono, 2007)) (see Figure 4.3). The heat map, 
incorporated in Figure 4.3, indicates densities of RefSeq genes within a specific genomic 
region, ranging from light gray (no RefSeq genes) to black (high density of RefSeq genes). 
To validate the determined DMRs by independent technologies, HiSeq 2000 and Infinium 
HumanMethylation BeadChip data of Appendix C were used. The mean difference between 
DNA methylation leveůƐǁŝƚŚŝŶDZƐĂƐƐĞƐƐĞĚďǇ^K>ŝ ?^-seq and HiSeq 2000 accounted 
for 0.02, emphasizing high concordance of both methods. The comparsion of ^K>ŝ ?^-seq 
and HumanMethylation BeadChip DNA methylation levels within DMRs required further 
criteria due to the notably lower density of sites 
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by at least 3 sites of the array, were considered. The mean difference between DNA 
methylation levels within DMRs assessed by ^K>ŝ ? ^ -seq and HumanMethylation 
BeadChip finally accounted for 0.12, which is marginally higher than the mean difference 
between the NGS methods. This larger difference is probably related to the sigmoidally 
distributed correlation between extreme DNA methylation levels of BS-seq and array data 
(see section 4.1) (see Appendix A). 
Conclusions, based on these DMRs, should be drawn with care, since PBMCs are only partly 
suitable as a reference-methylome for DAUDI. At least it could be observed that the 
majority of DMRs were located within genomic regions involving a high density of RefSeq 
genes (see Figure 4.3). 
 
 
Figure 4.3: Ideogram of DMRs in DAUDI and PBMCs. 
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4.5 Conclusion and Future Perspectives 
The generation of the first human methylomes at single base resolution by Lister et al. 
initiated a rapid development of NGS-based DNA methylation analysis over the past three 
years (Lister et al., 2009). After this publication and the establishment of associated 
biotechnological methods, the bottleneck of genome-wide DNA methylation analysis 
especially shifted from data production to data analysis. Findings, incorporated in this 
thesis, can be integrated into the recent development of BS-seq analysis in the following 
way. Before the publication of Lister et al., BS-seq of human genomes was only carried out 
on NGS platforms using base space encoded sequences (see section 2.1) and DNA 
methylation levels could be only verified by array-based or loci-specific sequencing 
methods. A bioinformatics tool for the analysis of color-space (see section 2.1) BS-seq data 
henceforth represents an alternative for a platform-independent validation (see Appendix 
A). BS-seq analysis of both base and color-space data poses considerable challenges. These 
challenges and the most appropriate way to analyze this type of data are described in 
Appendix B. So far, whole methylomes are available for human embryonic stem cells, fetal 
fibroblasts, peripheral blood mononuclear cells, and colon cancer cells (Lister et al., 2009, 
2011; Li et al., 2010; Hansen et al., 2011). The study, incorporated in Appendix C, analyzed a 
further human methylome derived from an endemic Burkitt ?Ɛ ůymphoma cell line. BS-seq 
was carried out for base and color-space data, where a high correlation (r=0.86) could be 
observed. This study revealed new methylome characteristics for B-cell lymphomas and 
introduced new approaches for correlation analyses of DNA methylation and transcriptional 
levels. The DAUDI methylome might prove valuable as a reference methylome for future 
epigenetic studies. 
Although whole methylome analysis can be carried out by BS-seq in a cost-efficient manner 
by now, there are still certain limitations. Firstly, current BS-seq methods analyze mixed 
populations of cell types. Consequently, BS-seq results only reflect the composition of 
methylomes of different cell types, which are difficult to interpret. Secondly, DNA molecules 
are amplified prior to the sequencing step (see section 2.1). This might lead to uneven 
distributions of bisulfite sequences, which interferes with the determination of DNA 
methylation levels. These limitations can be addressed by recently developed single-
molecule real-time sequencing (SMRT) methods, which enable the direct detection of DNA 
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methylation without prior bisulfite conversion. In SMRT sequencing, DNA polymerases 
catalyze the incorporation of fluorescently labeled nucleotides into complementary DNA 
strands. Each nucleotide is attached to one of four different fluorescent dyes (Flusberg et 
al., 2010). During the incorporation of a nucleotide the fluorescent tag is detected by a zero-
mode waveguide (an optical approach for studying single-molecule dynamics), and base 
calls are carried out based on the fluorescence of the underlying dye (Levene et al., 2003). 
The arrival times and durations of the resulting fluorescence pulses reveal information 
about polymerase kinetics, enabling the direct detection of epigenetic modifications, such 
as DNA methylation and hydroxymethylation (Flusberg et al., 2010; Song et al., 2012). These 
SMRT sequencing methods currently pass the end of the development phase and first test 
runs were already carried out. However, they still exhibit an increased per-base error rate 
and ambiguous results (Eid et al., 2009; Song et al., 2012). Once these methods are well-
established, they will be very helpful and cost-effective to simultaneously readout genetic 
and different epigenetic variations.  
DNA methylation was described to be associated with transcriptional silencing by 
quantitative studies comparing DNA methylation and transcriptional levels (Lister et al., 
2009, 2011; Li et al., 2010; Hansen et al., 2011). However, the underlying regulatory network 
and its interaction partners are not yet clear. To address this issue, all DNA-binding proteins, 
affected or unaffected by DNA methylation, should be identified. Especially transcription 
factors, which are predominantly active in regions upstream of genes, are of great interest. 
DNA methylation is the most studied epigenetic modification so far. Future studies need to 
analyze further epigenetic modifications and in particular histone modifications to a similar 
extent because possibly only the functional interaction of all epigenetic modifications 
clarifies their impact on transcriptional levels. This presumption can be exemplified by the 
following examples. On the one hand, Esteller stated that tumor-suppressor genes are 
inactivated by hypermethylation of CpG islands in their promoter regions, which directly 
influence the growth of tumors (Manel Esteller, 2008). This mechanism is reversible by so-
called demethylating and methylating agents, which can awake and silence genes involving 
hypermethylation and hypomethylation in their promoter region (Manel Esteller, 2008). On 
the other hand, Lister et al. pointed out that DNA methylation might only be a consequence 
of closed chromatin structure, where DNA methylation in embryonic stem cells might be 
lost during differentiation, resulting in accumulation of repressive chromatin marks 
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(Pelizzola and Ecker, 2010; Lister et al., 2009). In summary, further functional studies on 
epigenetic modifications should be carried out to better understand the mechanism of DNA 
methylation and its regulatory effect on transcriptional levels. 
 
In conclusion to my experience of the last three years, future computational epigenetic 
studies on DNA methylation should consider the following aspects. Firstly, it has to be 
explored to which extent DNA methylation is regulated by environmental factors. This 
phenomenon has to be studied regarding its stability or even inheritance, since it is also 
conceivable that a dynamic modification like DNA methylation is affected by environmental 
factors over a specific period of time and initial DNA methylation patterns are then re-
established. In this regard, DNA hydroxymethylation, a possible pathway for de-methylation, 
might emerge as a helpful access. Secondly, DNA methylation needs to be analyzed in large-
scale studies to assess its effect on different diseases. However, these studies involve critical 
challenges as for instance genetic-epigenetic interaction and the determination of 
appropriate features of variation in DNA methylation (single site alterations, DMRs, ASMs 
etc.). For this purpose, further whole methylomes of different cell types and tissues should 
be analyzed and categorized to specify appropriate genomic domains. Even though all these 
points minimize the amount of confounding factors for the analysis of DNA methylation, it 
will be very difficult to  ?ĐŽŶƚƌŽů ?such a dynamic modification and the following question will 
frequently come up: Is the observed alteration in DNA methylation the cause or the 
consequence of a specific disease? This question can possibly be addressed by the 
integration of all involved factors of the pathogenesis of a disease into for instance 
extended gene regulatory networks (GRNs), a system biological method to model DNA-
encoded interaction partners. The dynamics of DNA methylation requires GRNs to 
distinguish different diseases involving the same genotype but not the same epigenotype. 
Such a dynamic GRNs approach should initially be explored for a phenotype, where genetics 
and epigenetics and their interaction is investigated as far as possible. 
 
In summary,  ?dynamic times ? are ahead for research in DNA methylation analysis!
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ABSTRACT
Summary: Bisulfite sequencing, a combination of bisulfite treatment
and high-throughput sequencing, has proved to be a valuable
method for measuring DNA methylation at single base resolution.
Here, we present B-SOLANA, an approach for the analysis of two-
base encoding (colorspace) bisulfite sequencing data on the SOLiD
platform of Life Technologies. It includes the alignment of bisulfite
sequences and the determination of methylation levels in CpG as
well as non-CpG sequence contexts. B-SOLANA enables a fast and
accurate analysis of large raw sequence datasets.
Availability and implementation: The source code,
released under the GNU GPLv3 licence, is freely available at
http://code.google.com/p/bsolana/.
Contact: b.kreck@ikmb.uni-kiel.de
Supplementary information: Supplementary data are available at
Bioinformatics online.
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1 INTRODUCTION
Methylation at position 5 of cytosines is a major epigenetic
modification, which has an important impact on transcriptional
and regulatory processes of DNA (Holliday, 1975). It is a stable
modification of the genome which can be inherited from one
generation to the next, even though it can also be dynamically
changed by environmental influences. There are several methods
based on high-throughput sequencing, such as methylated DNA
immunoprecipitation sequencing (MeDIP-seq), methylated DNA
capture by affinity purification (MethylCap-seq) and BS-Seq, which
can provide good-quality genome-wide DNA methylation data
(Bock, 2010).
Methods that currently provide genome-wide methylation
patterns at single base resolution make use of bisulfite conversion
and high-throughput sequencing. The treatment of DNA with
sodium bisulfite has no effect on methylated cytosines, but it
specifically converts unmethylated cytosines to uracils, which are
converted to thymines during subsequent polymerase chain reaction
amplification. As a result of bisulfite conversion, the Watson and
Crick strands of bisulfite-treated DNA are no longer complementary
to each other, they become essentially different genomes. This fact
∗To whom correspondence should be addressed.
leads to an enlarged alignment reference space. The prevalence of
T’s that have replaced C’s leads to reduced complexity in bisulfite
sequences, which increases the bioinformatics challenge of BS-
Seq analysis. Bioinformatics tools for BS-Seq have generally fallen
into two categories: (i) methylation-aware alignment tools, which
consider cytosines and thymines as potential matches to genomic
cytosine positions and (ii) tools which convert any residual cytosines
in bisulfite sequences and all cytosines of the reference genomes into
thymines.
2 COLORSPACE BISULFITE SEQUENCING
Due to the two-base encoding of SOLiD sequencing, in silico
conversions of any residual bisulfite read cytosines into thymines,
which can be carried out in basespace data to avoid bisulfite-
mismatches during alignment, cannot be performed on bisulfite
colorspace sequences, because sequencing errors would lead to
the incorrect translation of colorspace to basespace (Supplementary
Fig. 1). There are ways to align bisulfite colorspace sequences with
methylation-aware alignment approaches, which convert bisulfite
colorspace sequences to basespace and index all theoretically
possible alignments by creating a hash table. Such an approach is
implemented in SOCS-B, which is based on the iterative version
of the Rabin–Karp algorithm (Ondov, 2010). Even though SOCS-B
turns out to be an accurate tool for the analysis of colorspace BS-Seq
datasets, it becomes very computationally intensive for complex
genomes such as the human genome (∼150 000 CPU hours for the
analysis of 500 Million sequences). Therefore, it is not efficient
for huge datasets like those produced in genome-wide methylation
analyses with average coverage depths ≥10X and genome size
≥1000 MB.
Here, we present B-SOLANA, a tool which performs sequence
alignment and methylation calling for colorspace bisulfite
sequencing. It is based on the established short-read aligner
Bowtie (Langmead, 2009) and SAMtools utilities for manipulating
alignments (Li, 2009). B-SOLANA is divided into four individual
steps: (i) indexing, (ii) mapping, (iii) determination of best alignment
and (iv) methylation calling.
The idea of B-SOLANA is to use Bowtie to uniquely align
bisulfite sequences to two different conversions of the reference
genome and determine best alignments from the combined set
of results. The analysis of whole methylomes of 23 eukaryotic
organisms shows a variable percentage of methylation at CpG
© The Author(s) 2011. Published by Oxford University Press.
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Table 1. The 485 990 920 SOLiD BS-Seq reads (50 bp), taken from
SRR204024 (Hansen, 2011), were analyzed with B-SOLANA and
MethylCoder (one mismatch allowed) B-SOLANA exhibits a high
correlation with the results of Hansen et al.
Hansen et al.a B-SOLANA MethylCoderb
Uniquely mapped reads (%) 37.83 49.84 19.23
CpG positions: % C 69.84 72.83 67.07
CpG positions: % T 30.03 26.97 32.93
Non-CpG positions: % C 0.20 0.22 0.69
Non-CpG positions: % T 99.76 99.70 99.31
aIncluding post-processing quality control.
bOnly cytosine and thymine base calls are included.
dinucleotides, whereas the percentage of methylated CHG and CHH
is always lower (Pelizzola, 2010). The approach of B-SOLANA
reduces the number of bisulfite-induced mismatches by considering
the prevalence of methylated cytosines in their different sequence
contexts.
In order to identify CpG and non-CpG methylation sites,
B-SOLANA aligns bisulfite sequences to two in-silico conversions
of the reference genome (Supplementary Fig. 2). In the first modified
reference genome, all cytosines in a non-CpG context are converted
to thymines (Conversion I). In the second, all cytosines, irrespective
of their sequence context, are converted to thymines (Conversion
II). After alignment to these converted genomes, B-SOLANA
determines the best alignment for each bisulfite sequence in the
following way: bisulfite sequences that are aligned to different
genomic positions in Conversions I and II are assigned to the
position with the lowest number of mismatches. Reads with the
same number of mismatches at different positions are ignored. In its
final step, B-SOLANA determines methylation levels. B-SOLANA
is compatible with 50 bp directional single-end libraries and allows
a simple adjustment for the upcoming read lengths.
B-SOLANA was designed to generate accurate results for
methylomes with a low percentage of methylation in non-CpG sites
(<5%). This includes most eukaryotic organisms, with mammalian
genomes typically having methylation levels of <3% in CHG and
<1% in CHH context (Pelizzola, 2010).
A detailed test of B-SOLANA was performed for genomic DNA
extracted from a human lymphoma cell line. The library was
prepared using a protocol for single-end SOLiD BS-Seq (Bormann
Chung, 2010) and sequencing of the bisulfite-converted DNA was
performed using SOLiD versions 3 Plus and 4. This generated
2.79 billion bisulfite reads of which ∼52% were mapped uniquely
(genome build hg19/NCBI 37). The methylation results obtained
by B-SOLANA were then compared to the Illumina Infinium
HumanMethylation450 BeadChip (450 k) assay, an established
methylation analysis method, as a quality control (Supplementary
Fig. 3). We observed high concordance between the results of the
two independent methods (99% of 450 k sites were also represented
in the B-SOLANA results) and the methylation levels of cytosines,
which were assayed by both methods displayed a very high
correlation (Pearson correlation r >0.93). As a proof of principle,
we also generated different simulated datasets, reflecting varying
CpG and non-CpG methylation levels. Encouragingly, the results
generated by B-SOLANA closely match the expected methylation
degrees (Supplementary Table 1).
A further approach for the analysis of colorspace BS-Seq
was published with the tool MethylCoder (Pedersen, 2011).
MethylCoder applies a conversion of any residual bisulfite read
cytosines into thymines, which leads to erroneous alignments,
as discussed above. Therefore, we compared B-SOLANA and
MethylCoder (one mismatch allowed) by analyzing 485 990 920
SOLiD BS-Seq reads (50 bp), taken from SRR204024 (Hansen,
2011). We found a high concordance between methylation calls of
Hansen et al., analyzed by their yet unpublished and unavailable
approach, and B-SOLANA. Moreover, B-SOLANA turns out to
have a significantly higher mapping efficiency.
As a platform-independent benchmark, we demonstrate that the
analysis of colorspace BS-Seq data of the fibroblast cell line
IMR90 is comparable to methylome data published by Lister et al.
(2009), who used a BS-Seq approach on the Illumina platform
(Supplementary Information 1).
3 CONCLUSIONS
We present an efficient tool for the analysis of large colorspace
BS-Seq data. B-SOLANA provides a fast and accurate all-in-one
approach, including alignment and methylation calling. It is easy
to use and generates an intuitive output, which can be used for
genome-wide DNA methylation analysis.
ACKNOWLEDGEMENTS
We thank Ole Ammerpohl for helpful discussions (Institute of
Human Genetics, Kiel), Gavin Meredith (Life Technologies, Foster
City CA, USA) for providing SOLiD BS-Seq data of IMR90 cells
and the sequencing facility at IKMB for helpful discussions and
support.
Funding: Start-up grant from the Medizinausschuss Schleswig
Holstein, the National Genome Research Network (NGFN) of
Germany (BMBF-funded); DFG cluster of excellence ‘Inflammation
at Interfaces’ (infrastructure support); BMBF in the framework of
the ICGC MMML-Seq project (to R.S. and J.R.).
Conflict of Interest: none declared.
REFERENCES
Bock,C. et al. (2010) Quantitative comparison of genome-wide DNA methylation
mapping technologies. Nat. Biotechnol., 28, 1106–1114.
Bormann Chung,C.A. et al. (2010) Whole methylome analysis by ultra-deep sequencing
using two-base encoding. PLoS One, 5, e9320.
Hansen,K. et al. (2011) Increased methylation variation in epigenetic domains across
cancer types. Nat. Genet., 43, 768–775.
Holliday,R. et al. (1975) DNA modification mechanisms and gene activity during
development. Science, 187, 226–232.
Langmead,B. et al. (2009) Ultrafast and memory-efficient alignment of short DNA
sequences to the human genome. Genome Biol., 10, R25.
Lister,R. et al. (2009) Human DNA methylomes at base resolution show widespread
epigenomic differences. Nature, 462, 315–322.
Li,H. et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics,
25, 2078–2079.
Ondov,B.D. et al. (2010) An alignment algorithm for bisulfite sequencing using the
Applied Biosystems SOLiD System. Bioinformatics, 26, 1901–1902.
Pedersen,B. et al. (2011) MethylCoder: Software Pipeline for Bisulfite-Treated
Sequences. Bioinformatics, 27, 2435–2436.
Pelizzola,M. et al. (2010) The DNA methylome. FEBS Lett., 585, 1994–2000.
429
 at U
B K
iel on M
ay 25, 2012
http://bioinform
atics.oxfordjournals.org/
D
ow
nloaded from
 
 Appendix A  
 
 
 
 
 
Supplemental Information 
 
 
 ?-SOLANA: An approach for the analysis of two-base encoding 
ďŝƐƵůĨŝƚĞƐĞƋƵĞŶĐŝŶŐĚĂƚĂ ? 
 
Kreck B, Marnellos G, Richter J, Krueger F, Siebert R, Franke A 
Bioinformatics (2011), 2012 Feb 1;28(3):428-9. Epub 2011 Dec 6 
 
Supplementary Information 
 
 
 
Supplementary Figure 1 (A) A SNP position in colorspace appears as two adjacent color transitions. (B) 
A measurement error in colorspace appears as a single color transition. (C) In silico conversion of C to T 
in bisulfite reads carrying a measurement error abrogates mapping to an equally converted reference 
sequence. This figure was adapted from Krueger F, Kreck B, et al., DNA Methylome Analysis Using Short 
Bisulfite Reads, in press. 
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Supplementary Figure 2 B-SOLANA performs four different mappings. Each bisulfite-treated sequence 
will be mapped to a modified reference genome in which all cytosines in non-CpG context are in silico 
converted to thymines and to a reference genome in which all cytosines, irrespective of their sequence 
context, are converted to thymines. B-SOLANA determines the best mapping in terms of lowest number 
of mismatches. Consequently, different methylation levels can be assessed. 
 
 
 
 
 
 
 
 
 
 
 
>>ATGGACmGCCTATGACTGAACmACmGCmGAT>> (bisulfite sequence)
>>ATGGACGTTTATGATTGAATACGCGAT>>
(Forward-reference conversion I (non-CpG C to T))
<<TATTTGCGGATATTGATTTGTGCGCTA<<
(Reverse-reference conversion I (non-CpG C to T))
>>ATGGATGTTTATGATTGAATATGTGAT>>
(Forward-reference conversion II (C to T))
<<TATTTGTGGATATTGATTTGTGTGTTA<<
(Reverse-reference conversion II (C to T))
9
  
Supplementary Figure 3 (A) Comparison of SOLiD BS-Seq to a single Illumina Infinium 
HumanMethylation450 BeadChip restricted to methylation calls of Typ I data. The distributions depict 
the residuals as the differences between SOLiD BS-Seq methylation levels and Infinium beta values, 
where values close to 0 mean that equal methylation levels were inferred by both methods. The green, 
blue, red and orange graphs represent the distribution of residuals of cytosines covered by at least 5, 10, 
15 and 20 bisulfite sequences, respectively. Higher read coverage generally results in narrower residual 
profiles, i.e. better correlation. The bimodal distribution of the residuals has a technology specific 
explanation. Unmethylated and fully methylated sites assessed by the 450k assay are usually not detected 
with beta values of 0 and 1 but rather assigned to beta values next to ~0.05 and ~0.94 In contrast, in BS-
Seq unmethylated and fully methylated sites correspond to methylation levels of 0 and 1. (C,D) This fact 
and the distribution of methylation levels (C,D) explain that the maxima in the distribution of residuals 
are located at ~-0.05 (0-0.05) and ~0.06 (1-0.94). Thus, the correlation of the 450k assay and BS-Seq is 
distributed sigmoidally.  (B) Scatter plot of methylation sites, which were assessed by 450k assay and BS-
Seq FRYHUDJH  ), shows a high correlation (Pearson correlation r=0.96). Bands at 0, 0.5, 1 (y-axis) 
correspond to the sigmoidal shift of the two assays at homozygous unmethylated, heterozygous 
methylated and homozygous methylated sites.  (C,D) Different distribution profiles of methylation levels 
in the 450k assay and BS-Seq, explaining the sigmoidal form of (A). 
  
Simulated data 1% CH methylation 3% CH methylation 5% CH methylation 
10% CG methylation 10.36 CG / 0.95 CH 9.79 CG / 2.62 CH 10.02 CG / 4.05 CH 
20% CG methylation 20.35 CG / 0.96 CH 20.00 CG / 2.60 CH 19.82 CG / 4.07 CH 
30% CG methylation 30.09 CG / 0.94 CH 29.83 CG / 2.59 CH 29.72 CG / 4.04 CH 
40% CG methylation 40.70 CG / 0.96 CH 40.68 CG / 2.61 CH 40.47 CG / 4.03 CH 
50% CG methylation 51.04 CG / 0.95 CH 50.77 CG / 2.66 CH 50.79 CG / 4.02 CH 
60% CG methylation 60.79 CG / 0.94 CH 61.00 CG / 2.62 CH 61.27 CG / 4.03 CH 
70% CG methylation 70.70 CG / 0.94 CH 70.98 CG / 2.61 CH 71.58 CG / 4.05 CH 
80% CG methylation 80.55 CG / 0.95 CH 80.36 CG / 2.59 CH 81.17 CG / 4.09 CH 
90% CG methylation 89.97 CG / 0.96 CH 89.92 CG / 2.63 CH 90.03 CG / 4.08 CH 
 
 
Supplementary Table 1 The accuracy of B-SOLANA was tested using simulation data from Sherman 
(bisulfite-treated Read FastQ Simulator (http://www.bioinformatics.bbsrc.ac.uk/projects/sherman/)). One 
hundred thousand reads (genome build HG19/NCBI 37) with different rates of bisulfite conversion (10% 
&*PHWK\ODWLRQ&+PHWK\ODWLRQ- any combinations) were analyzed as indicated. 
B-SOLANA is able to accurately detect various levels of simulated methylation when methylation in 
non?CpG context is fairly low (<5%). The latter is the case for most eukaryotic genomes, with 
mammalian genomes typically having methylation levels of less than 3% in CHG and less than 1% in 
CHH context (Pelizzola, 2010). 
 
 
 
 
Pelizzola, M., et al. (2010) The DNA methylome, FEBS Lett., 585, 1994±2000 
  
 Hansen et al.* B-SOLANA MethylCoder** 
Uniquely mapped reads (in %) (adenoma I) 32.13 42.60 10.58 
CpG positions:  % C (adenoma I) 66.29 70.12 65.68 
CpG positions:  % T (adenoma I) 33.59 29.70 34.32 
Non-CpG positions: % C (adenoma I) 0.24 0.25 1.31 
Non-CpG positions:  % T (adenoma I) 99.73 99.67 98.69 
 
   
Uniquely mapped reads (in %) (cancer I) 37.48 49.66 18.47 
CpG positions: % C (cancer I) 62.79 67.63 61.73 
CpG positions: % T (cancer I) 37.08 32.17 38.27 
Non-CpG positions: % C (cancer I) 0.23 0.24 0.69 
Non-CpG positions: % T (cancer I) 99.74 99.68 99.17 
 
* including post-processing quality control 
** only cytosine and thymine base calls are included  
 
 
Supplementary Table 2 Comparison of B-SOLANA and MethylCoder by analyzing SOLiD BS-Seq 
reads (50 bp), taken from (SRR204022 (adenoma I) and SRR204026 (cancer I)). The methylation calls of 
B-SOLANA show a high concordance with the results reported by Hansen et al., analyzed with their 
unpublished and unavailable approach. The mapping efficiencies of B-SOLANA and MethylCoder are 
substantially higher and dramatically lower, respectively, than reported by Hansen et al.. 
 
 
 
 
 
 
 
 
 
Supplementary Information 1 We include data of a SOLiD bisulfite sequencing run of IMR90, the 
same human diploid fibroblast strain which was also analyzed by Lister et al. (Lister 2009). Sequencing 
was performed using SOLiD version 3 which generated 515,699,253 bisulfite reads. The results were 
compared to those generated by Lister et al., who worked with BS-Seq data generated on the Illumina 
platform. For this purpose we used their publically available data at 
http://neomorph.salk.edu/human_methylome/ and used LiftOver (http://genome.ucsc.edu/cgi-
bin/hgLiftOver) to convert the data from HG18/NCBI 36 to HG19/NCBI 37. We performed correlation 
analyses for two biological replicates of IMR90 generated by Lister et al. and for colorspace bisulfite 
sequencing data of IMR90 compared to the combined set of results of Lister et al.. Both correlation 
analyses use CG methylation calls which are covered by at least five sequences and were present in both 
samples (either the two replicates of the Lister et al. data or colorspace vs. Lister et al. data). Calculations 
of the correlations yield the following results:  
 
 
 
 
These similar results let us conclude that bisulfite sequencing data generated on the SOLiD platform and 
the Illumina platform are comparable, despite the fact that the samples were derived from separate 
biological preparations of the IMR90 cell line.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lister, R., et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic 
differences, Nature, 462, 315-322. 
 Pearson r 
Replicates sequenced on the Illumina platform 0.80 
Colorspace BS-Seq vs. BS-Seq on the Illumina platform 0.74 
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DNA methylation involves the addition of a methyl 
group to the C5 carbon residue (5mC) of cytosines 
by DNA methyltransferases1,2. DNA methylation is 
an important epigenetic mechanism used by higher 
eukaryotes and is involved in several key physiologi-
cal processes, including regulation of gene expression, 
X-chromosome inactivation, imprinting, and silencing 
of germline-specific genes and repetitive elements3. 
Patterns of methylation are stably maintained through 
somatic cell division and can be inherited across gen-
erations. These patterns are sometimes perturbed in 
important human diseases, such as imprinting disor-
ders and cancer3–5. Understanding how methylation 
patterns are established and maintained is therefore 
of great importance.
The sequence context in which a cytosine occurs is a 
key factor in determining the regulation of its methyl-
ation. Cytosines that occur as part of a C-G dinucleo-
tide (CpG) are often highly methylated (~60–80% in 
mammals2) and are regulated differently to cytosines 
in other contexts. CpG methylation usually occurs on 
both DNA strands1 to maintain methylation at CpGs 
during DNA replication. In contrast, non-CpG meth-
ylation must be re-established de novo after each cell 
division. Although it is present at considerable levels 
during early development or in pluripotent cell types6–8, 
most non-CpG cytosines are generally unmethylated 
in differentiated tissues (~0.3–3% in mammals2).
As methylated cytosines are susceptible to spon-
taneous conversion into thymines through chemical 
DNA methylome analysis using short 
bisulfite sequencing data
Felix Krueger1,3, Benjamin Kreck2,3, Andre Franke2 & Simon R Andrews1
Bisulfite conversion of genomic DNA combined with next-generation sequencing 
(BS-seq) is widely used to measure the methylation state of a whole genome, the 
methylome, at single-base resolution. However, analysis of BS-seq data still poses a 
considerable challenge. Here we summarize the challenges of BS-seq mapping as they 
apply to both base and color-space data. We also explore the effect of sequencing 
errors and contaminants on inferred methylation levels and recommend the most 
appropriate way to analyze this type of data.
 deamination, they tend to be generally underrepre-
sented in the genome9,10, and they are often grouped in 
dense patches termed CpG islands. These islands tend 
to be unmethylated in the germline and are conse-
quently less vulnerable to spontaneous deamination11. 
CpG islands are frequently associated with promoters, 
and the regulation of promoter methylation has been 
shown to affect the expression of the corresponding 
transcripts. Traditionally, CpG islands were defined 
using sequence-composition analysis12–14 which pre-
dicted that the mouse genome contained a substan-
tially lower number of CpG islands than the human 
genome. However, a recent report demonstrated that 
the occurrence of functional CpG islands is in fact 
quite similar in the two organisms15.
Measuring methylation
Several methods exist for measuring DNA methyla-
tion at specific genomic loci, and these have been 
reviewed recently16,17. They range from methylated 
DNA immunoprecipitation or methyl binding protein 
enrichment of methylated fragments18–20 to digestion 
with methylation-sensitive restriction enzymes21 and 
bisulfite modification of DNA22. Comparisons of these 
methods showed that they all can be used to produce 
accurate DNA methylation data21,23,24.
During bisulfite sequencing the treatment of 
DNA with sodium bisulfite converts cytosines into 
uracils, whereas methylcytosines remain unmodified. 
Uracils are read as thymines by DNA polymerase, so 
1Bioinformatics Group, The Babraham Institute, Cambridge, UK. 2Institute of Clinical Molecular Biology, Christian Albrechts University, 
Kiel, Germany. 3These authors contributed equally to this work. Correspondence should be addressed to A.F. (a.franke@mucosa.de) or 
S.R.A. (simon.andrews@babraham.ac.uk).
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 amplifying bisulfite-treated DNA by PCR yields products in which 
unmethylated cytosines appear as thymines. By comparing the 
modified DNA with the original sequence, the methylation state 
of the original DNA can therefore be inferred. Bisulfite treatment 
of 5-hydroxymethylcytosine (5hmC) yields a similar intermediate 
to 5mC, meaning that BS-seq can be used to detect whether a 
position is (hydroxy-) methylated but not to determine the exact 
type of modification21,25 (Fig. 1). This limitation does not apply 
to antibody-based techniques, which can be used to specifically 
enrich 5hmC26–28.
Capillary electrophoresis–based bisulfite sequencing was consid-
ered the gold standard for methylation analysis because of its clear 
readout and single-base resolution22, but it could only be applied 
to relatively small regions. New sequencing technologies mean that 
BS-seq is now a viable option for the sequencing of entire mam-
malian methylomes6–8,29–32 (Supplementary Table 1).
For researchers primarily interested in CpG island methylation, 
the cost of bisulfite sequencing can be reduced by enriching CpG-
dense regions by digesting genomic DNA with a methylation-
insensitive restriction enzyme containing a C-G as part of its 
recognition site and selecting short fragments6,30,33. Even though 
the selected fragments are used to interrogate only a few percent 
of the genome, these data are informative for the majority of CpG 
islands. This approach, termed reduced representation BS-seq 
(RRBS), has been extensively described and compared to other 
techniques23,33–35, and several genome-wide methylation maps 
based on RRBS have been reported6,30.
In this Review we provide an overview of the computational 
analysis of bisulfite sequencing data. We highlight points to con-
sider when designing a BS-seq experiment and point out pitfalls 
that can occur during the initial analysis. We also discuss dif-
ferent alignment strategies and their implementation by current 
bioinformatic tools. In particular, we present the main differences 
between the analysis of base space (Illumina) and color space 
(SOLiD, Applied Biosystems) BS-seq data.
Challenges of BS-seq data mapping
As the methylation state of bisulfite-treated DNA must be inferred 
by comparison to an unmodified reference sequence, a correct 
alignment is of critical importance. This is challenging because 
the aligned sequences do not exactly match the reference, and the 
complexity of the libraries is reduced. Also, as cytosine methyl-
ation is not symmetrical, the two strands of DNA in the reference 
genome must be considered separately. A single site can have a 
different methylation state in different cells. Thus, when sequenc-
ing cell mixtures or tissue fractions, the percentage of methylation 
at each site needs to be determined36.
When performing an alignment one must discriminate between 
different types of bisulfite-treated DNA libraries (for a schematic 
drawing, see ref. 16). In the first, termed directional libraries, adapters 
are attached to the DNA fragments such that only the original 
top or bottom strands will be sequenced7,30. Alternatively, all four 
DNA strands that arise through bisulfite treatment and subsequent 
PCR amplification can be sequenced with the same frequency in 
nondirectional libraries32,37,38. BS-seq mapping may therefore 
require up to four different strand alignments to be analyzed for 
each sequence. Because of the complexity of BS-seq alignments, 
standard sequence alignment software cannot be used. However, 
several different tools for BS-seq analysis have been developed.
Base-space BS-seq data alignments
Methylation-‘aware’ alignment tools consider both cytosine and 
thymine as potential matches to a genomic cytosine. This strategy 
provides the highest possible mapping efficiency (high sensitivity) 
because it makes optimal use of the information present in the 
reads. However, a drawback of this technique is that methylated 
sequences will be aligned with greater efficiency because they 
carry more information than their unmethylated counterparts, 
leading this type of aligner to overestimate methylation levels.
Alternatively, in unbiased approaches usually any residual 
cytosines in the BS-seq read and all cytosines in the reference 
genome are converted into thymines before the alignment is per-
formed7,30. This means that the read sequence to be aligned is 
unaffected by its methylation state. It also means that there will be 
an exact match between the converted read and converted genome 
sequence so that standard sequence alignment tools can be used 
to perform the mapping39,40. This approach, however, comes at 
the cost of slightly reduced mapping efficiencies (Fig. 2a).
BS-seq in color space
In contrast to the intuitive base-space sequence generated by 
Illumina sequencers, SOLiD sequencing (Applied Biosystems) 
encodes its reads in color space such that each color resembles 
the transition from one base to the next41. Single-nucleotide poly-
morphisms (SNPs) can be called with high confidence because 
they will result in two adjacent color changes, whereas technical 
errors are indicated by a single color change (Supplementary 
Fig. 1a,b). Owing to the way color-space encoding works, 
residual cytosines are correctly converted into thymines in the 
bisulfite reads in silico before the mapping only if the reads are 
completely error-free. A single measurement error in the read 
would lead to incorrect conversions throughout the rest of the 
read (Supplementary Fig. 1c). As a consequence, the in silico 
cytosine to thymine conversion, which guarantees unbiased align-
ments, should not be performed on color-space datasets.
Current tools to align color space BS-seq data to a reference 
genome either use methylation-aware alignments (SOCS-B42), 
which can be computationally intensive for complex genomes, 
PCR amplification
Bisulfite conversion
Top strand
mC
OT
CTOT
CTOB
OB
mC mC mC
mC
Bottom strand
Figure 1 | Effect of bisulfite treatment of DNA. Bisulfite conversion of 
genomic DNA and subsequent PCR amplification gives rise to two PCR 
products and up to four potentially different DNA fragments for any given 
locus. (Hydroxy)methylated cytosine residues are resistant to bisulfite 
conversion and can be used as a readout of the DNA methylation state. 
mC, 5-methylcytosine; hmC, 5-hydroxymethylcytosine; OT, original top 
strand; CTOT, strand complementary to the original top strand; OB, 
original bottom strand; and CTOB, strand complementary to the original 
bottom strand.
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or align reads to in silico–converted versions of the reference 
genome, with bisulfite-induced mismatches are treated as normal 
mismatches. As different levels of methylation can result in 
increased numbers of mismatches to the reference genome, this 
approach is, however, not free of bias. One possibility to reduce 
mapping bias is to apply different in silico conversions to the refer-
ence genome and determine best alignments from the combined 
set of results of different mapping runs. This approach, however, 
requires prior knowledge of the methylation characteristics of the 
organism to be analyzed.
BS-seq data alignment tools
Several tools have been developed for the analysis of BS-seq data-
sets17. These not only differ considerably regarding their align-
ment speed, flexibility and ease of use but also in the information 
they report. Many older BS-seq data aligners only reported a 
bisulfite read mapping output, and the user had to extract meth-
ylation information from the alignments. More recent tools 
provide a comprehensive methylation output, which enables the 
end user to explore the biological effects of methylation more 
quickly39,40,43. Most recent tools, such as Bismark40, BS-Seeker39 
or B-SOLANA44, use existing short-read aligners (Bowtie45 for 
the mentioned tools) and handle the requirements unique to BS-
seq data analysis internally.
An example for a color-space alignment tool is B-SOLANA, with 
which reads are initially aligned to a reference genome in which 
all cytosines in non-CpG context had been in silico–converted 
into thymines and are then aligned to a second reference genome 
in which cytosines in all sequence contexts are converted into 
thymines. Unlike bisulfite alignments in base space (Fig. 2b), this 
method is not suited to accurate detection of arbitrary methylation 
levels in unknown samples because a high degree of methylation in 
the non-CpG context would produce too many mismatches in the 
alignment step (Fig. 2c). This would lead to a dramatic decrease in 
mapping efficiency and an apparent bias toward hypomethylation 
in the non-CpG context. However, for the majority of eukaryotic 
genomes with less than 5% methylation in non-CpG context2, 
alignments can be generated efficiently and accurately (Fig. 2d).
In the rest of this Review we use Bismark to illustrate dif-
ferent aspects of BS-seq analysis. Bismark can accurately 
detect the simulated methylation state of cytosines in any 
sequence context while the mapping efficiency is completely 
unaffected (Fig. 2b). We summarize details of different software 
packages for BS-seq data analysis in Table 1.
Once a dataset consisting of best alignments has been deter-
mined based on predefined alignment criteria, the methylation 
state of positions involving cytosines in the reference sequence 
can be inferred. Then these methylation calls can serve to deter-
mine the ratios of methylated versus unmethylated cytosines at 
every position assayed. Later, analyses of the methylation data 
could include looking at minimum read depths, determining 
methylation states of individual cytosines or genomic features, 
or estimating cytosine-conversion errors or false discovery rates. 
The biological analysis of methylome data is manifold and beyond 
the scope of this review.
Factors affecting the accuracy of methylation calls
Two key factors are crucial when determining the methylation 
state of a read from a BS-seq experiment. First, the sequence of 
the read must be correct and derive entirely from a bisulfite-
 converted sequence in the original genome. Second, the read must 
be correctly mapped to the corresponding position of the targeted 
genome. Failure to meet either of these criteria will result in the 
generation of incorrect methylation calls and, in extreme cases, 
the noise from these miscalls can adversely affect the conclusions 
drawn from the whole experiment. If a base is misaligned or mis-
called, then on average it will display a methylation rate of 50% 
because both cytosine and thymine are equally likely to be mis-
placed against a genomic cytosine. If the true methylation level is 
close to 0% or 100%, then a relatively small number of errors can 
disproportionally shift the predicted overall level of methylation.
Base-call qualities
In real data, the quality of base calls tends to fall as the length of 
the reads increases (Supplementary Fig. 2a). As base-call errors 
are random, the frequency for each base will tend toward 25% 
each at positions with high error rates. Another source of con-
tamination that can lead to a change in base composition is the 
presence of (methylated) adaptor sequences, which we discuss 
below. Such deviations of the average nucleotide distribution 
toward later cycles of a library can usually be spotted in a base-
composition analysis (Supplementary Fig. 2b). A tradeoff can be 
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made, in which longer reads increase coverage but also increase 
the number of incorrect methylation calls. Although it would be 
possible to weight a bisulfite methylation call based on the quality 
of the original base call, this is not currently done by any of the 
commonly used analysis tools and would only be of benefit for 
miscalled bases rather than misaligned reads.
To quantify the effect of miscalled bases, we simulated a 75–
base-pair read dataset containing no methylation and added 
random miscalls at rates between 0.01% and 10% following 
an exponential decay model over the length of the sequence 
(Supplementary Fig. 2c). As the error rate increased, so did the 
apparent methylation level.
A way to counteract methylation miscalls or mismapping events 
as a consequence of base call errors in the reads, is to select strict 
alignment parameters. To demonstrate this, we simulated bisulfite 
reads with sequences carrying varying numbers of false base calls 
and aligned this dataset to the mouse reference genome using 
increasingly stringent cutoffs. Increasing the mapping stringency 
prevented sequences with several mismatches from aligning, thus 
reducing the number of erroneously inferred methylation states 
(Supplementary Fig. 2d) but at the cost of reduced mapping effi-
ciency. A better way of decreasing methylation call errors from 
such poor quality data is to trim off low-quality base calls before 
read alignments are carried out. Such adaptive quality trimming 
can be performed with several publically available tools, such 
as cutadapt (http://code.google.com/p/cutadapt/), the FASTX 
toolkit (http://hannonlab.cshl.edu/fastx_toolkit/index.html), 
PRINSEQ46 (http://prinseq.sourceforge.net/), SolexaQA47 (http://
solexaqa.sourceforge.net/), Trimmomatic (http://www.usadellab.
org/cms/index.php?page=trimmomatic) and others.
Sequencing into the adaptor
In many libraries, a proportion of reads will run through the insert 
and begin to sequence the adaptor on the 3` end. Including adaptor 
sequence in a read will dramatically decrease the mapping efficiency 
of the read and will add a subset of random methylation calls.
We simulated the addition of varying lengths of Illumina adaptor 
sequence onto a BS-seq library containing no base call errors and 
measured the effect on both mapping efficiency and methylation 
calls (Supplementary Fig. 3a). The mapping efficiency decreased 
steadily with increasing adaptor contamination, but methylation 
errors were tightly linked to the sequence of the adaptor. Each 
addition of a cytosine in the adaptor caused a dramatic spike in the 
observed level of methylation (data not shown). Nondirectional 
libraries are even more susceptible to adaptor contamination as 
the introduction of guanine or adenine into reads aligning to the 
complementary bisulfite strands can introduce additional errors. 
Appropriate steps to identify and remove adaptor contamina-
tion, such as k-mer analysis (Supplementary Fig. 3b) with tools 
such as FastQC (http://www.bioinformatics.bbsrc.ac.uk/projects/
fastqc/) and adaptor-trimming software (for example, cutadapt, 
the FASTX toolkit, Trimmomatic, FAR (http://sourceforge.net/
projects/theflexibleadap/) and others), should therefore always 
be taken before read alignments are carried out.
When we introduced both base call quality degradation and 
adaptor contamination into simulated BS-seq data reads, we 
observed a greatly reduced mapping efficiency compared to 
perfect genomic sequences (Supplementary Fig. 3c). When we 
universally trimmed the same sequences to shorter read lengths, Ta
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the mapping efficiency increased, reaching a maximum between 
50 and 75 base pairs. This demonstrates that increasing the read 
length of bisulfite sequences does not necessarily translate into a 
linear increase in methylation information gained from an experi-
ment. Similarly, paired-end reads do not automatically yield twice 
the amount of methylation data compared to single-end experi-
ments because they result in a considerable amount of redundant 
methylation calls where both reads overlap.
Bisulfite conversion rate
In a BS-seq experiment we implicitly assume that all unmethyl-
ated cytosines are converted into thymines. However, this con-
version may not run to completion. Incomplete conversion of 
unmethylated cytosines is indistinguishable from methylation 
and can thus introduce false positive methylation calls. In con-
trast, prolonged bisulfite treatment causes the sample to degrade 
in a way which enriches the small amount of remaining material 
for methylated reads.
Some studies have tried to avoid non-conversion errors by 
removing reads that exceeded an arbitrary threshold of methyl-
ation in a non-CpG context7,30,37; however, this procedure 
assumes very low methylation in a non-CpG context and hence 
introduces a potential bias against methylated reads. One option 
for estimating the bisulfite conversion rate is to use spike-in 
controls of nonnative DNA with a known methylation state. 
However, it should be kept in mind that such controls might 
not necessarily have the same conversion properties as the DNA 
sample to be analyzed.
End repair
It is crucial that the DNA methylation state of each fragment is not 
artificially modified before treatment with bisulfite because any 
amplification by a polymerase will erase any methylation marks 
that were present. In RRBS experiments, for instance, each frag-
ment is generated by the digestion of a genome with a restriction 
endonuclease. The most commonly used enzyme for this type of 
library is MspI, which, upon cleavage, leaves a 5` C-G overhang 
on the ends of each fragment33. To allow the addition of sequenc-
ing adapters, the overhangs are end-repaired using either methyl-
ated or unmethylated cytosines. These filled-in bases will align 
perfectly against the reference genome but will not maintain the 
original methylation state, and care must therefore be taken to 
exclude these bases from methylation calling. This problem only 
affects the 3` end of reads when the read length is longer than the 
fragment to be sequenced (RRBS is probably more affected as frag-
ments are usually size-selected to be 40 to 220 base pairs24,33). In 
such cases, reads should be screened for the occurrence of cytosine 
residues or a second MspI site just before reading into a potential 
adaptor contamination toward the 3` end and trimmed back until 
the modified bases have been removed. In addition, paired-end 
or nondirectional RRBS libraries may also contain reads originat-
ing from filled-in MspI sites at the beginning of the reads, which 
consequently need to be excluded from downstream analysis38.
Single-nucleotide variants
Any SNPs that are a cytosine in the reference genome but a thym-
ine in the experimental sample would appear as consistent calls 
of unmethylated cytosines. Such errors would be impossible to 
detect from the quality of the reads because the base calls would 
be good and only the isolated nature of the effect seen might 
suggest that it is a technical rather than a biological effect. Both 
BS-seq alignments and methylation calls assume that the genomic 
reference sequence that reads are compared to is correct. Thus, 
if no SNP information is available, one has to expect a certain 
extent of systematic errors. These effects could be minimized by 
integrating available genomic-variation data, for example, from 
SNP databases into the reference sequence before bisulfite align-
ments are carried out or by using nucleotide information of the 
opposing genomic strand.
Conclusions
The primary analysis of BS-seq data should always start with a 
thorough assessment of the raw sequence data. Reads with low 
base call qualities or adaptor contamination should be identi-
fied and trimmed rigorously, even if this entails the risk of losing 
a few base pairs of real data, because the gain of confidence in 
correct alignments and methylation calls outweighs this minor 
data loss. Considering that mapping efficiencies of BS-seq and 
standard genomic reads converge quickly for read lengths greater 
than 40 base pairs (Fig. 1a), single-end reads of 50–75 base pairs 
seem to offer a reasonable compromise, providing good mapping 
capacity without running into problems associated with longer 
read lengths.
Mandatory
action
Data type Optional
action
Example
tools
FastQC
PRINSEQ*
SolexaQA*
Cutadapt
FASTX toolkit*
PRINSEQ*
SolexaQA*
Trimmomatic*
Cutadapt
FASTX toolkit*
Trimmomatic*
Bismark*
BRAT*
BSMAP*
BS-Seeker*
MethylCoder*
RMAP-BS*
B-SOLANA
SOCS-B
and others
Picard
Quality control
report
Quality control
report
Check duplication
Deduplicate
Adaptive quality
trimming
Adapter trimming
Raw sequences
Quality-controlled
sequences
Quality-trimmed
sequences
Adapter-trimmed
sequences
Aligned sequences
Methylation calls
Quality
control
Sequence
alignment
Methylation
calling
Figure 3 | Recommended workflow for the primary analysis of BS-seq data. 
Black arrows depict required steps, gray arrows indicate optional steps.  
*, only works with base-space data.
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For base-space data, it is critical not to tolerate a high level of 
non-bisulfite mismatches (mismatches not induced by bisulfite 
treatment—that is, all mismatches other than (unmethylated) 
C-to-T mismatches) during the alignments because this allows 
reads to align to incorrect positions in the genome, resulting in 
false methylation calls. This can become especially relevant for 
reads originating from highly repetitive sites or from regions that 
are not yet part of the genome assembly. Stringent alignments are 
equally important for color-space data, but because color-space 
mapping approaches work differently, the strategy may have to 
be adapted to the individual needs of specific tools.
Many of the aspects of BS-seq discussed here, taken on their 
own, do not seem to have particularly drastic effects. Their com-
bination, however, could easily lead to several million false methyl-
ation calls, which might have profound effects on the biological 
conclusions drawn from an experiment. Additional attention 
should be paid to reducing the number of artifacts that can only 
be spotted after the alignments have been performed. Duplicate 
reads or regions displaying abnormally high read coverage should 
be excluded from the analysis because they can comprise a size-
able proportion of the experiment and thereby introduce con-
siderable bias.
Given one has a choice before starting an experiment, it is cur-
rently most convenient to opt for a platform generating base-space 
data because it can measure methylation over a wide dynamic 
range of methylation levels in any cytosine context with equal effi-
ciencies, and most available tools are tailored to this kind of data. 
For small genomes or genomes fulfilling certain criteria regarding 
their methylation state, there are now also good tools available to 
handle color-space reads.
The best practices recommended here (Fig. 3) apply to data 
generated on current sequencing platforms. It will be interesting 
to see whether forthcoming single-molecule sequencing tech-
nologies will be able to live up to their promise to revolutionize 
the way in which methylation is measured.
Note: Supplementary information is available on the Nature Methods website.
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ADS Homosapiens 11.5x Illumina 1
ADS ?adipose Homosapiens 12.3x Illumina 1
ADS ?iPSC Homosapiens 13.1x Illumina 1
FF Homosapiens 8.4x Illumina 1
FF ?iPSC6.9 Homosapiens 4.8x Illumina 1
FF ?iPSC19.7 Homosapiens 4.7x Illumina 1
FF ?iPSC19.11 Homosapiens 4.1x Illumina 1
FFiPSC19.11 ?BMP4 Homosapiens 8.5x Illumina 1
IMR90 Homosapiens 14.7 x Illumina 2
IMR90 ?iPSC Homosapiens 4.5x Illumina 1
H1 Homosapiens 14.0 x Illumina 2
H1 ?BMP4 Homosapiens 16.5x Illumina 1
H9 Homosapiens 4.6x Illumina 1
fibroblasts(newborn) Homosapiens 9.0x Illumina 3
fibroblasts(hESC ?derived) Homosapiens 9.0x Illumina 3
WA09hESC Homosapiens 9.0 x Illumina 3
PeripheralBloodMC Homosapiens 12.3x Illumina 4
HSF1hESC Homosapiens 2.6 x Illumina 5
Arabidopsis Arabidopsisthaliana 20x Illumina 6
Arabidopsis Arabidopsisthaliana 8.0x Illumina 7
HoneyBee Apismellifera 20x Illumina 8
Silkworm Bombyxmori 7.4x Illumina 9
Escherichiacoli Escherichiacoli >270x SOLiD 10
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Abstract 35 
Recent epigenomic studies suggest Burkitt lymphoma (BL), in contrast to its few 36 
chromosomal alterations, to carry a high number of DNA methylation changes. 37 
Therefore, we here generated and analyzed the DNA methylome of an archetypal 38 
endemic BL cell line (DAUDI) at base-pair resolution using different platforms. The 39 
extent of cytosine methylation in CpG dinucleotides significantly varied between 40 
nuclear (68.99%), mitochondrial (6.43%) and EBV (80.18%) genomes. Despite being 41 
rare on the genome-wide level, non-CpG methylation was significantly enriched 42 
within genes. Gene expression was strongly associated with lacking CpG methylation 43 
immediately at transcription start sites. Expressed and non-expressed genes were 44 
associated with distinct patterns of gene body methylation with remarkably sharp 45 
transitions at exon-intron borders. At lower resolution, we could confirm presence of 46 
this pattern also in primary sporadic BL. Our findings show that the mechanisms of 47 
DNA methylation in lymphomas, which are associated with transcriptional 48 
regulation, extend by far the usually studied promoter methylation. 49 
 50 
Keywords:  Burkitt Lymphoma, Epigenetics, DNA Methylation, Bisulfite Sequencing 51 
 4 
Introduction 52 
The Burkitt translocation t(8;14), first identified in the 1970s in biopsies and cell lines 53 
from BL,
1,2
 and its variants juxtapose the MYC oncogene to one of the 54 
immunoglobulin (IG) loci.
3
 Nowadays, it is assumed that (nearly) all BL carry an IG-55 
MYC translocation, rendering this somatic mutation a diagnostic marker for all three 56 
subtypes of BL (endemic, sporadic and immunodeficiency-related BL).  57 
In contrast to many other lymphomas, BL show a quite simple karyotype, i.e. with 58 
few if any chromosomal changes in addition to the IG-MYC translocation.
4
 Though 59 
there is evidence for some few recurrent secondary genetic changes the number of 60 
epigenetic alterations in BL as compared to normal B-cell subsets seems to 61 
outnumber the genetic changes by far. Indeed, we and others have identified several 62 
hundred genes showing de novo DNA methylation in aggressive B-cell lymphoma, 63 
including BL as compared to normal B-cell subsets.
5-7
 Nevertheless, the mentioned 64 
DNA methylation studies focused on a maximum of probably 10% (by HELP assays) 65 
of the CpGs of the genome, and were biased towards promoter regions and CpG 66 
islands and did not systematically analyze non-CpG methylation.
5-8
 Therefore, we 67 
here aimed at generating a complete DNA-methylome of a BL, allowing for unbiased 68 
analyses of all cytosines in the genome. To this end, we chose the archetypal DAUDI 69 
cell line, established from an endemic BL that was derived from a 16-year-old African 70 
male patient in 1967.
9,10
 We selected this cell line as it has been pivotal for the 71 
identification of t(8;14), still carries a simple karyotype despite being many years in 72 
culture and because it shows the prototypic features of eBL. Moreover, considering 73 
the strong association of eBL with Epstein-Barr virus (EBV) infection, the EBV-positive 74 
 5 
DAUDI cell line offers the opportunity for a direct comparison of its lymphoma and 75 
EBV methylomes. 76 
 77 
Methods 78 
Genomic characterization of DAUDI cells 79 
DAUDI cells (ACC- ? ? ? ? ĂŶĚ E ǁĞƌĞ ƉƌŽǀŝĚĞĚ ďǇ ƚŚĞ  “ĞƵƚƐĐŚĞ ^ĂŵŵůƵŶŐ ǀŽŶ80 
Mikroorganismen und Zellkulturen ? (DSMZ). Chromosomal R-banding analysis and 81 
Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA) analysis were 82 
performed according to standard methods. Whole exome capture and sequencing 83 
ǁĞƌĞĐĂƌƌŝĞĚŽƵƚƵƐŝŶŐ/ůůƵŵŝŶĂ ?ƐdƌƵ^ĞƋ Exome Enrichment Kit (Illumina, San Diego, 84 
CA, USA). A subset of mutations identified by exome sequencing was verified by 85 
Sanger Sequencing (see Supplementary Data). 86 
 87 
DNA methylation profiling using Bisulfite-Sequencing (BS-seq) 88 
We performed genome-wide BS-ƐĞƋŽŶƚŚĞ^K>ŝ ? ?>ŝĨĞdĞĐŚŶŽůŽŐŝĞƐ ?ĂƌůƐďĂĚ ? ?89 
and the HiSeq 2000 platform. 90 
For the prior, two bisulfite-ĐŽŶǀĞƌƚĞĚ^K>ŝ ?ĨƌĂŐŵĞŶƚůŝďƌĂƌŝĞƐǁĞƌĞĐŽŶƐƚƌƵĐƚĞĚĂƐ91 
described previously.
11,12
 Briefly, 15 µg of genomic DNA were sheared to 92 
approximately 125 bp using a Covaris S2 system (Life Technologies, Carlsbad, CA, 93 
USA). After end-repair of the DNA fragments, methyl-P1 and P2 adaptors were 94 
ligated (for details on methyl-P1 and P2 see Ranade et al.
12
). The DNA was then size 95 
selected on an agarose gel and nick-translated with a modified dNTP Mix containing 96 
methyl-dCTPs instead of regular dCTPs in order to protect the adaptor sequences 97 
 6 
during bisulfite conversion. Bisulfite conversion was carried out in solution as 98 
described previously
12
 and recovered DNA fragments were PCR amplified using 8 99 
cycles. The bisulfite converted fragment library was clonally amplified on SOLiD P1 100 
beads using emulsion PCR. Templated (P2 positive) beads were then enriched and 101 
deposited on a slide for sequencing. 102 
For the HiSeq 2000 analyses, genomic DNA was sonicated using the Diagenode 103 
Bioruptor (Diagenode, Denville, NJ) to a final size distribution ranging from 100 bp to 104 
800 bp. Libraries were prepared from the sonicated DNA using the NEBNext Sample 105 
Prep Master Mix Set 1 (New England Biolabs, Ipswich, MA) according to the 106 
ŵĂŶƵĨĂĐƚƵƌĞƌƐ ? ŝŶƐƚƌƵĐƚŝŽŶƐ ? /ůůƵŵŝŶĂ ?ƐĂƌůǇĐĐĞƐƐDĞƚŚǇůĂƚŝŽŶĚĂƉƚĞƌ KůŝŐŽǁĂƐ107 
used for the ligation. The adapter-ligated DNA was treated with sodium bisulfite 108 
using the Imprint DNA Modification Kit (Sigma, St. Louis, MO) according to the 109 
ŵĂŶƵĨĂĐƚƵƌĞƌƐ ? ŝŶƐƚƌƵĐƚŝŽŶƐ ? dŚĞ ďŝƐƵůĨŝƚĞ-treated product was amplified with 16 110 
cycles using a uracil stalling-free polymerase (Agilent, Santa Clara, CA, USA) followed 111 
by size selection on a gel (200 bp  ? 250 bp) and purification with the Qiagen Gel 112 
Extraction Kit (Qiagen, Hilden, Germany). 113 
SĞƋƵĞŶĐŝŶŐ ƵƐŝŶŐ ^K>ŝ ? ǀ ? ? ? ĐŚĞŵŝƐƚƌǇ ĂĐĐŽƌĚŝŶŐ ƚŽ ŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐ114 
yielding 50 bp reads, which were analyzed with B-SOLANA.
13,14 
 115 
For the HiSeq 2000 analyses, V3 chemistry was used ĂĐĐŽƌĚŝŶŐ ƚŽ ŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ116 
instructions yielding 100 bp reads, which were analyzed with Bismark.
14,15
 117 
 118 
 119 
DNA methylation profiling using universal BeadArrays 120 
 7 
DNA from DAUDI and four proto-typic sporadic BL was bisulfite-converted using the 121 
Zymo EZ DNA Methylation Kit (Zymo Research, Orange, CA, USA) and hybridized to 122 
the HumanMethylation450 DNA Analysis BeadChip (Illumina). Hybridization signals 123 
were analyzed using GenomeStudio software (ver. 2011.1, Methylation Analysis 124 
Module ver. 1.9.0; Illumina Inc). 125 
 126 
Gene expression analyses 127 
We combined expression data from the U133A gene chip (Affymetrix, Santa Clara, 128 
CA) and RNA-sĞƋƵƐŝŶŐ ƚŚĞ ^K>ŝ ?ƉůĂƚĨŽƌŵ  ?>ŝĨĞ dĞĐŚŶŽlogies, Carlsbad, CA). The 129 
RNA-seq library was prepared by a modified Whole Transcriptome Analysis Kit 130 
(WTAK) (Life Technologies, Carlsbad, CA) and analyzed as previously described,
16
 131 
with the modification that we used TopHat
17
 to carry out alignments.  132 
 133 
See the provided Supplemental Material and Methods section for details. 134 
 135 
Results and Discussion 136 
To obtain a base-pair resolution DNA methylome of a prototypic eBL we subjected 137 
the widely-used t(8;14)- and EBV-positive DAUDI cell line to full bisulfite-sequencing, 138 
using two different platforms. By karyotyping, SNP-array analysis and exome 139 
sequencing we confirmed that the cells under study show the typical features of BL, 140 
including the t(8;14) plus a few secondary chromosomal changes and mutations in 141 
genes like ID3 and B2M (Supplemental Table 1).  142 
We aligned 79.9 Gb of bisulfite sĞƋƵĞŶĐĞƐ ŽĨ ƚŚĞ ^K>ŝ ? ĂŶĚ  ? ? ? 'ďŽĨ the HiSeq 143 
2000 platform and compared the results to the DNA methylation levels determined 144 
 8 
by HumanMethylation450 BeadChip analysis (Supplemental Figure S1). We 145 
ŽďƐĞƌǀĞĚŚŝŐŚĐŽƌƌĞůĂƚŝŽŶŽĨƚŚĞ^K>ŝ ?ĚĂƚĂǁŝƚŚďŽƚŚƚŚĞ sequence-based HiSeq 146 
2000 (Pearson r=0.86; Supplemental Figure S2) and the array-based (Pearson r=0.96, 147 
Supplemental Figure S3) methylation levels. This led us to focus our further analyses 148 
ŽŶƚŚĞŵŽƐƚĞǆƚĞŶƐŝǀĞĚĂƚĂƐĞƚĚĞƌŝǀĞĚĨƌŽŵ^K>ŝ ?^-seq.  149 
In total, 91.1% of all CpG sites and 90.2% of all non-CpG sites of the genome were 150 
ĐŽǀĞƌĞĚ ďǇ Ăƚ ůĞĂƐƚ ĨŝǀĞ ^K>ŝ ? ƌĞĂĚƐ  ?Supplemental Figure S4). On the genome-151 
wide level 68.99% cytosines in CpG dinucleotides were methylated which is in line 152 
with previous pyrosequencing-based determinations using LUMA (Figure 1). In 153 
contrast, the 450K BeadArray shows a mean methylation level of 59.24%, which is 154 
mostly due to the selection bias of the array-loci, which are predominantly located 155 
within regions upstream of genes. We observed a mean CpG methylation level of 156 
70.88% in high-complex regions, whereas mean CpG methylation in repeats 157 
accounted for 65.79% in LINEs and 78.84% in SINEs (Supplemental Figure S5). 158 
Bisulfite sequencing shows the DNA methylation patterns on the forward and 159 
reverse strand to be comparably established (Pearson r=0.90). 160 
Considering the recent description of non-CpG methylation in ESC, and the fact that 161 
the MYC oncogene deregulated in BL is also one of the four factors used to induce a 162 
stem cell-like phenotype in differentiated cells,
18
 we analyzed the level of non-CpG 163 
methylation. The genome-wide fraction of methylated cytosines in a non-CpG 164 
context does not exceed the respective threshold of 0.003 given by the 165 
unmethylated lambda control DNA that was tested in parallel.
8
 Moreover, we 166 
confirmed absence of non-CpG methylation at hallmark sites described in ESC
8
 by BS 167 
pyrosequencing (Supplemental Figure S6). Despite this overall low frequency of non-168 
 9 
CpG methylation, we could identify a remarkable 6.7-fold enrichment of non-CpG 169 
methylcytosines within genes (p<2.2×10
-16
; Figure 2). Such non-CpG methylation 170 
might be linked to transcriptional activity (Supplemental Figure S7). 171 
We next determined the sequence-based methylation status of 969 genes recently 172 
shown by us to exhibit de novo promoter hypermethylation in mature aggressive B-173 
cell lymphoma (including BL) as compared to normal B-cells.
5
 We could confirm that 174 
in DAUDI cells  ? ? ? ? ?A? ŽĨ ƚŚĞƐĞ ŐĞŶĞƐ ŚĂǀĞ Ă E ŵĞƚŚǇůĂƚŝŽŶ ůĞǀĞů A? ? ?A? ŝŶ ƚŚĞŝƌ175 
promoter region and lack transcription. As compared to all other RefSeq genes, the 176 
mean CpG methylation level within promoter regions of the 969 genes was 177 
significantly higher (84% vs. 41%; Supplemental Tables S2). 178 
Gene expression analyses confirmed that DAUDI cells show the typical signature of 179 
molecular Burkitt Lymphoma (mBL).
19
 Correlating methylation and expression 180 
patterns in our data revealed that significant presence of transcripts is associated 181 
with absence of DNA methylation particular at and closely around the transcription 182 
start site (TSS). In contrast, DNA methylation exactly at the TSS correlates with lack 183 
of transcription (Figure 3). Whereas the group of non-expressed genes showed an 184 
overall high mean DNA methylation level across the whole gene with highest 185 
methylation levels in exons, genomic regions comprising expressed genes were 186 
characterized by particular high methylation levels in the first intron. Moreover, the 187 
patterns of both expressed and non-expressed genes were characterized by sharp 188 
transitions of methylation levels at exon-intron borders (Figure 3). 189 
In order to exclude that this pattern of DNA methylation is limited to the DAUDI cell 190 
line, we analyzed 450K BeadArray data from four primary prototypic sporadic BL 191 
(sBL) Though DAUDI contains significantly more methylated CpGs than the primary 192 
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sBL (59.24% vs. 47.50%) the targets of DNA methylation are coincident suggesting a 193 
significant epigenomic (and regulation thereof) analogy (Supplemental Figure S8). 194 
We observed a similar association of transcriptional activity and DNA methylation in 195 
sBL like in DAUDI cells, both around the TSS and in the gene body (Supplemental 196 
Figure S9). These findings indicate that correlation analyses between DNA 197 
methylation and expression in BL strongly depend on the localization of the CpGs 198 
under study. 199 
Finally, we studied the DNA methylation of the mitochondrial and EBV genomes of 200 
DAUDI cells.
20-22
 We estimated 80 EBV and 370 mitochondrial copies per DAUDI cell 201 
based on coverage analyses, which is in accordance with previous studies.
23
 Whereas 202 
mitochondrial DNA is mostly unmethylated (mean methylation 6.43%; Figure 1), CpG 203 
methylation in the human and EBV genome is comparably distributed, though the 204 
EBV genome exhibits hardly any fully methylated sites (Figure 1). Overall, EBV shows 205 
a high level of DNA methylation (mean methylation 80.18%), as it was previously 206 
shown for BL cell lines.
24
 Nevertheless, DNA methylation within the EBV genome 207 
correlates with expression only at high transcript levels (FPKM>=15) (Supplemental 208 
Figure S10). 209 
In summary, we have characterized the nuclear DNA methylome of an endemic BL 210 
along with its mitochondrial and EBV methylome. We unravel significant differences 211 
between the different sub-methylomes and moreover show that gene transcription 212 
is associated with complex patterns of methylation, extending beyond simple 213 
promoter and CpG methylation. As the DAUDI cell line has been used over decades 214 
in many laboratories in the world, the obtained methylome data might serve as a 215 
 ?ƌĞĨĞƌĞŶĐĞĞƉŝŐĞŶŽŵĞ ?ĨŽƌĨƵƚƵƌĞƐƚƵĚŝĞƐ ? 216 
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Figure Legends 317 
Figure 1. Distribution of CpG DNA-methylation in DAUDI cells 318 
The graphs show genome-wide distributions of CpG methylation of the human 319 
nuclear, EBV and mitochondrial genomes. The y-axis indicates DNA methylation 320 
ůĞǀĞůƐĂƐƐĞƐƐĞĚďǇ^K>ŝ ?^ -seq. Green: Human nuclear CpG methylation, Red: EBV 321 
CpG methylation, Blue: Mitochondrial CpG methylation. 322 
 323 
Figure 2. Distribution of non-CpG DNA-methylation in DAUDI cells 324 
Significantly methylated nonCpG sites of DAUDI within RefSeq genes (comprising 325 
424,969,306 non-CpGs) are 6.7-fold enriched compared to those outside of RefSeq 326 
genes (comprising 689,750,660 non-CpGs). Red: Fraction of significantly methylated 327 
non-CpGs of DAUDI within RefSeq genes, Blue: Fraction of significantly methylated 328 
non-CpGs of DAUDI outside of RefSeq genes. 329 
 330 
Figure 3. Correlation of DNA methylation levels and transcriptional states 331 
CpG methylation levels were averaged for annotated RefSeq gene regions and 332 
transcripts are clustered by their expression level in present (n=7662 transcripts) and 333 
absent (n=5429 transcripts) calls. A strong dependency of the location of CpGs 334 
related to their distance to the TSS and the transcript expression level can be 335 
observed. Green: Average methylation pattern for present transcripts, Red: Average 336 
methylation pattern for absent transcripts. 337 
  338 
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Supplementary Material and Methods 25 
Characterization of the DAUDI cell line 26 
The cell line DAUDI has been established in 1967 from an endemic BL (eBL) 27 
presenting in the left orbita of a 16-year-old African boy.
1
 The cell line is positive for 28 
EBV (HHV-4) but lacks expression of immediate-early protein BZLF-1 and lately 29 
expressed capsid protein. By PCR, the cell line is negative for HBV, HCV, HHV-8, HIV, 30 
HTLV-I/II and SMRV. The immunophenotype has been determined as CD3 -, CD10 +, 31 
CD19 +, CD20 +, CD37 +, CD38 +, cyCD79a +, CD80 +, CD138 -, HLA-DR +, sm/cyIgM +, 32 
sm/cyIgG -, sm/cykappa +, sm/cylambda  ? (data available from DSMZ at 33 
www.dsmz.de). 34 
Cytogenetic analysis using chromosomal R-banding revealed a karyotype 35 
46,XY,t(8;14)(q24;q32). These findings are in line with those from Multicolor 36 
Fluorescence In Situ Hybridization (M-FISH) of the DAUDI cell line and showing that it 37 
has remained karyotypically stable along decades of continuous cultivation (E.M.M.P 38 
et al., manuscript in preparation). 39 
The Genome-Wide Human SNP Array 6.0 was performed according to 40 
ŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽů  ?ĨĨǇŵĞƚƌŝǆ ?^ĂŶƚĂůĂƌĂ ? ?ƵƐŝŶŐ ƚŚĞ&ůƵŝĚŝĐƐ^ƚĂƚŝŽŶ ? ? ?41 
and the GeneChip Scanner 3000 (Affymetrix, Santa Clara, CA). The Birdseed v2 42 
algorithm was used to genotype tumour samples. Copy number analysis, Loss of 43 
heterozygosity (LOH) analysis and segmentation was calculated using Genotyping 44 
Console software version 3.0 (Affymetrix, Santa Clara, CA). Segments with significant 45 
imbalances were considered as copy number aberration only if they consisted of at 46 
least 20 sequential probes, comprised a minimal size of 100 kb, and mapped outside 47 
 3 
known copy number polymorphisms. Data analysis revealed two gains and four 48 
chromosomal losses: arr 4q13.3(75,205,069-75,765,823)x1,5p11.1(46,361,933-49 
49,591,883)x1,7q31.32q31.33(121,093,529-123,683,639)x1, 50 
8q24.21q24.3(128,682,912-146,268,947)x3,14q32.31q32.33(101,614,613-51 
105,400,262)x4,15q12q21.1(25,151,945-45,290,444)x1 (NCBI36/hg 18) 52 
 53 
 54 
 55 
Whole Exome Sequencing 56 
We ƉĞƌĨŽƌŵĞĚǁŚŽůĞĞǆŽŵĞĐĂƉƚƵƌĞƵƐŝŶŐ/ůůƵŵŝŶĂ ?ƐdƌƵ^ĞƋǆŽŵĞŶƌŝĐŚŵĞŶƚ<ŝƚ57 
and sequencing of 2x100 bp paired-end reads was performed on one quarter lane of 58 
an Illumina HiSeq2000. Reads were mapped against the human reference genome 59 
build hg18 using BWA,
2
 followed by the removal of PCR duplicates with Picard 60 
(http://picard.sourceforge.net). Variant calling was performed with SAMtools 61 
mpileup and GATK,
3,4
 for SNP annotation and filtering we applied our own in-house 62 
tool snpActs. InDels were annotated using ANNOVAR.
5
 63 
A total of 62,578 on target SNPs were filtered against 8 exomes of healthy 64 
individuals, allowing for a maximum frequency of 1% in the 1000 genomes project 65 
and keeping only non-synonymous and splice-site SNPs that were not present in 66 
dbSNP130 resulting in 2,313 SNP after filtering. 67 
 68 
Sanger Sequencing 69 
Selected SNVs detected by exome sequencing were verified by Sanger Sequencing 70 
on an ABI Sequencer 3100 (Applied Biosystems). 71 
 4 
Primer sequences used for validation of potentially protein changing mutations: 72 
Gene Primer name Sequence 5´-3´ 
B2M B2M_FP TCCCTCTCTCTAACCTGGCAC 
B2M_RP ACTTGGAGAAGGGAAGTCACG 
TET2 TET2_FP TGCATGCAAAATACAGGTTTC 
TET2_RP CAGCTTGCAGGTGGATTCTC 
ID3 ID3_FP TCCAGGCAGGCTCTATAAGTG 
ID3_RP CCGAGTGAGTGGCAATTTTT 
KIT KIT_FP CACAGACCCAGAAGTGACCA 
KIT_RP TACCTGGCCTCACTTTCAGG 
 73 
Gene expression analyses 74 
U133A raw data was analyzed using the panp package of the R statistical software 75 
(Peter Warren, panp R package version 1.20.1.) and the Affymetrix Microarray 76 
Analysis Suite version 5.0 (MAS).
6
 77 
The paired-end RNA-seq library was prepared using the RiboMinus ? ƵŬĂƌǇŽƚĞ78 
/ƐŽůĂƚŝŽŶ<ŝƚĂŶĚƚŚĞZŝďŽDŝŶƵƐ ?ŽŶĐĞŶƚƌĂƚŝŽŶ<ŝƚ ?>ŝĨĞdĞĐŚŶŽůŽŐŝĞƐ ?ĂƌůƐďĂĚ ? ? ?79 
^ƵďƐĞƋƵĞŶƚůǇ ?ƚŚĞ^K>ŝ ?tŚŽůĞdƌĂŶƐĐƌŝƉƚŽŵĞŶĂůǇƐŝƐ<ŝƚ ?td< ?ǁĂƐƉĞƌĨŽƌŵĞĚ80 
and sequencing was carried out at 50 bp in the forward and 35 bp in the reverse 81 
ĚŝƌĞĐƚŝŽŶƵƐŝŶŐ^K>ŝ ?ǀ ? ? ?ĐŚĞŵŝƐƚƌǇĂĐĐŽƌĚŝŶŐƚŽŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ? 82 
A combined set of results was generated in the following manner. Present 83 
transcripts are the intersection of U133A-determined present calls and RNA-seq calls 84 
consisting of a FPKM value >0.01. However, transcripts including an absent 85 
ĂƐƐŝŐŶŵĞŶƚ ďǇ ƚŚĞ h ? ? ? ĂƐƐĂǇ ĂŶĚ Ă &W<D ǀĂůƵĞ A? ? ? ? ? ǁĞƌĞĐŽŶƐŝĚĞƌĞĚ ĂƐ ĂŶ86 
absent call. In total, we could assess 7662 present calls and 5429 absent calls. 87 
 5 
Expression analyses of EBV are restricted to RNA-seq data, due to missing EBV-88 
annotations on the U133A-chip. We raise the FPKM threshold for transcripts within 89 
ƚŚĞsŐĞŶŽŵĞĨƌŽŵ ? ? ? ?ƚŽ ?ĞƐƚŝŵĂƚĞĚďǇƚŚĞŶƵŵďĞƌŽĨу ? ? ?ĐŽƉŝĞƐ ?ĐŽŵƉĂƌĞĚ90 
ƚŽу ? ?ĐŽƉŝĞƐĂƐƐĞƐƐĞĚďǇĐŽǀĞƌĂŐĞĂŶĂůǇƐĞƐ ?ŽĨǀŝƌƵƐƉĂƌƚŝcles per cell.7  91 
 92 
Identification and analyses of significant non-CpG methylation sites 93 
Potential methylcytosines in a non-CpG context were detected as described by Lister 94 
et al..
8
 Hereby, the binomial distribution was used to exclude false positive non-CpG 95 
methylation sites arisen by incomplete bisulfite conversion. Furthermore, we 96 
corrected for potential non-CpG sites including a mutation (N to G) in their adjacent 97 
base (+1). Although the genome-wide amount of methylated cytosines in non-CpG 98 
context does not exceed the expected threshold, given by an estimation based on 99 
spiked-in lambda phage, we were able to identify a local enrichment of non-CpG 100 
methylcytosines within gene regions (Figure 1B). In detail, we observed 9533 RefSeq 101 
genes containing significant non-CpG sites. The ratio of these present and absent 102 
transcripts is slightly enriched compared to the genome-wide level (OR=1.11). 103 
However there is no significant difference between absent and present transcripts in 104 
terms of the ratio of significant and existing non-CpG sites within RefSeq genes 105 
(Table S2). 106 
 107 
HumanMethylation450 DNA Analysis BeadArray  108 
DNA of DAUDI cells and of four primary sporadic BL was subjected to 450K 109 
BeadArray-analysis. Primary samples were proto-typic IG-MYC positive BL derived 110 
from children. Bisulfite conversion was performed using the Zymo EZ DNA 111 
 6 
DĞƚŚǇůĂƚŝŽŶ<ŝƚ  ?ǇŵŽZĞƐĞĂƌĐŚ ?KƌĂŶŐĞ ? ?h^ )ĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ112 
instruction. Subsequent analysis steps were performed according to the 113 
ŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽůŵĞĂƐƵƌŝŶŐNA methylation at >485,000 CpG sites selected 114 
from more than 21,000 genes in parallel. Hybridization signals were analyzed using 115 
GenomeStudio software (default settings; GenomeStudio ver. 2011.1, Methylation 116 
Analysis Module ver. 1.9.0; Illumina Inc) and internal controls for normalization.  117 
 118 
Bisulfite Pyrosequencing 119 
Bisulfite pyrosequencing of two regions identified by Lister et al., to carry non-CpG 120 
methylation in differentiated and stem cells were pyrosequenced.
8
 Bisulfite 121 
pyrosequencing was carried out as described by Lamprecht et al..
9
 Briefly, genomic 122 
DNA was bisulfite converted using the EpiTect Bisulfite Conversion Kit (Qiagen). In a 123 
subsequent PCR amplification locus-specific primers were used with one primer 124 
biotinylated at the 5´ end (sequencing primer sequences are shown below). 125 
Amplification was verified by agarose gel electrophoresis. Using the VacuumPrep 126 
Tool (Biotage, Uppsala, Schweden) single strands were prepared followed by a 127 
denaturation step at 85qC for two minutes and final sequencing primer 128 
hybridization. Pyrosequencing was performed using the Pyrosequencer ID and the 129 
DNA methylation analysis software Pyro Q-CpG 1.0.9 (Biotage), which was also used 130 
to evaluate the ratio T:C (mC:C) at the CpG sites analyzed. All assays were optimized 131 
and validated using commercially available completely methylated DNA (Millipore) 132 
and pooled DNA isolated from peripheral blood of 10 healthy male and female 133 
controls, respectively. 134 
 135 
 7 
Primer sequences used for bisulfite pyrosequencing: 136 
Primer name 5´-3´sequence 5´modification 
methyl_chr1_FP AAATTTGGTTTTTTTATATGG   
methyl_chr1_RP CTAAAACCTCTTAAACTTTTATCA Biotin 
methyl_chr1_seq GGTTTTTTTATATGGTTA  
methyl_chr10_FP GATGGGTGATTTTTTAGA   
methyl_chr10_RP ACATTTCCTACAATTTCAA Biotin 
methyl_chr10_seqa TGGGTGATTTTTTAGAGTT   
methyl_chr10_seqb GATTTGTGGAAGATAGA   
 137 
 138 
Luminometric Methylation Assay (LUMA) 139 
To analyze global genomic DNA methylation, LUMA was performed as previously 140 
described.
10
  141 
 142 
Data availability: Methylome data are available at 143 
sftp://134.245.63.215/export/home/daudi (login: daudi; password: 144 
daudismethylome2012) 145 
  146 
 8 
Supplementary Results 147 
 148 
Supplemental Table 1: SNP filtering of Exome sequencing data (a) and potentially 149 
protein changing mutations detected by Exome sequencing and validated by 150 
Sanger Sequencing (b). 151 
 152 
Supplementary Table 1a 153 
SNPs on target 62,578 
 ? 
SNPs not in healthy controls
* 
25,752 
 ? 
SNPs involving a frequency in 1000 genomes pilot of 
max. 1% 
18,822 
 ? 
SNPs not in dbSNP130 10,650 
 ? 
non-synonymous SNPs
**
 2,313 
*
Healthy controls are taken from published datasets
11,12
, whereas we solely used the 154 
HapMap probes published by Ng et al..
12
 Additionally, we included exome data 155 
generated in-house. 
**
Due to lack of germline control from the patients from which 156 
the DAUDI cell line has been established it is not possible to differentiate somatic 157 
(lymphoma-associated) mutations from germline variants. 158 
 159 
Supplementary Table 1b 160 
Gene chr position ref/ alt allele Aa consequence note 
B2M 15 42791039 G/C p.Met1Ile Confirmed 
 9 
TET2 4 106377217 C/T p.Ser911Leu Confirmed 
ID3 
1 23758264 G/A p.Leu52Val Confirmed 
1 23758345 G/C p.Gln81* Confirmed 
KIT 4 55259372 C/T p.Ala67Ser Confirmed 
 161 
  162 
 10 
 163 
Supplemental Figure S1: Comparison of four HumanMethylation450 BeadArray 164 
replicates 165 
Scatter plots depict the comparison of all four replicates of 450K runs of DAUDI cells. 166 
ůůŽĨƚŚĞŵƐŚŽǁŚŝŐŚĐŽƌƌĞůĂƚŝŽŶƐĂŵŽŶŐĞĂĐŚŽƚŚĞƌƌA? ? ? ? ? ? 167 
168 
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 169 
Supplemental Figure S ? ?ŽŵƉĂƌŝƐŽŶŽĨ^K>ŝ ?ĂŶĚ/ůůƵŵŝŶĂ^-seq 170 
dŚĞ ŚŝƐƚŽŐƌĂŵ ĚĞƉŝĐƚƐ ƚŚĞ ĚŝĨĨĞƌĞŶĐĞƐ  ?^K>ŝ ? -^seq  ? Illumina BS-seq) in 171 
methylation levels ((methylated reads)/(unmethylated reads + methylated reads)) 172 
for CpGs with coverage of at least 5 reads. Values close to 0.0 indicate that equal 173 
methylation levels were inferred by both methods. Both approaches show 174 
comparable genome-wide DNA methylation levels r=0.86. 175 
176 
Residuals (methylationSOLiD  ?methylationIllumina)
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 177 
^ƵƉƉůĞŵĞŶƚĂů&ŝŐƵƌĞ^ ? ?ŽŵƉĂƌŝƐŽŶŽĨ^K>ŝ ?^-seq and HumanMethylation450 178 
Beadchip data. dŚĞƐĐĂƚƚĞƌƉůŽƚƐĚĞƉŝĐƚƚŚĞĐŽŵƉĂƌŝƐŽŶŽĨ^K>ŝ ?^-seq and 450k 179 
methylation levels. Higher read coverage generally results in better correlation. (a) 180 
ŝŶĐůƵĚĞƐ^K>ŝ ?^-^ĞƋĚĂƚĂǁŝƚŚĐŽǀĞƌĂŐĞA? ? ?(b ?ŝŶĐůƵĚĞƐ^K>ŝ ?-^Seq data with 181 
ĐŽǀĞƌĂŐĞA? ? ? ?(c) incluĚĞƐ ^K>ŝ ? ^-^ĞƋ ĚĂƚĂ ǁŝƚŚ ĐŽǀĞƌĂŐĞA? ? ? ĂŶĚ(d) includes 182 
^K>ŝ ?^-^ĞƋĚĂƚĂǁŝƚŚĐŽǀĞƌĂŐĞA? ? ? ?ůůŽĨƚŚĞŵƐŚŽǁŚŝŐŚĐŽƌƌĞůĂƚŝŽŶƌA? ? ? ? ? ?183 
184 
 13 
 185 
^ƵƉƉůĞŵĞŶƚĂů&ŝŐƵƌĞ^ ? ?ŽǀĞƌĂŐĞĨŽƌ^K>ŝ ?^-seq  186 
WĞƌĐĞŶƚĂŐĞ ŽĨ ƵŶŝƋƵĞůǇ ĂůŝŐŶĞĚ ^K>ŝ ? ^-Seq reads to the human reference 187 
(hg19/NCBI 37) for the forward (a) and the reverse (b) strand. Both strand coverages 188 
are equally distributed. 189 
190 
 14 
 191 
Supplemental Figure S5: Genome-wide comparison of DNA methylation for 192 
different annotated repeat regions. In total, 64.82% of all CpG sites within 193 
annotated repeat regions and 84.05% of all CpG sites outside of repeat regions were 194 
covered. Bar plots show distributions of DNA methylation levels within non-repeat 195 
regions, SINEs, LINEs, LTRs and Satellites. The y-axis indicates DNA methylation levels 196 
 ? ?ŵĞƚŚǇůĂƚĞĚƌĞĂĚƐ ? ? ?ƵŶŵĞƚŚǇůĂƚĞĚƌĞĂĚƐнŵĞƚŚǇůĂƚĞĚƌĞĂ Ɛ ? ?ĂƐƐĞƐƐĞĚďǇ^K>ŝ ?197 
BS-seq.  198 
MeanMethylation(Outside of repeat regions)=0.68 199 
MeanMethylation(SINEs)=0.79, MeanMethylation(LINEs)=0.66 200 
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MeanMethylation(LTRs)=0.64, MeanMethylation(Satellites)=0.63 201 
DNA methylation patterns on the forward and reverse strand were comparably 202 
established (Pearson r=0.90).203 
 16 
204 
Supplemental Figure S6: Comparison of hallmark non-CpG sites showing significant 205 
non-CpG methylation in ESC cells
3 
analyzed by BS pyrosequencing and methylome 206 
sequencing. No significant non-CpG methylation could be identified for hallmark 207 
sites on chromosome 1 (a) and chromosome 10 (b). For each region above the IGV 208 
plot of the bisulfite methylome data and below the BS pyrosequencing data are 209 
 17 
shown. The results of pyrosequencing are indicated as percentiles above each 210 
potentially methylated position (colored in grey). In each region one CpG site was 211 
analyzed which showed near to complete methylation.  212 
 213 
214 
 18 
 215 
Supplemental Figure S7: Correlation analysis of significantly methylated non-CpG 216 
sites and transcriptional levels within RefSeq genes in DAUDI cells: RefSeq genes 217 
ǁĞƌĞĐůƵƐƚĞƌĞĚ  ?ǆс ? ?  ?фǆч ? ? ? ? ? ?  ? ? ? ? ?фǆч ? ? ? ? ? ?  ? ? ? ? ?фǆч ? ? ? ?  ďǇƚŚĞŝƌĨƌĂĐƚŝŽŶŽĨ218 
significantly methylated non-CpG sites related to the number of referenced non-219 
CpGs within the respective RefSeq gene. The y-axis depicts transcriptional levels 220 
measured by FPKM values. A modest positive correlation between significantly 221 
methylated non-CpG sites and respective transcriptional levels can be observed. 222 
Similar results could be observed for transcriptional levels assessed by the Affymterix 223 
U133A chip (p ?ǆс ? ?  ? ? ? ? ?чǆч ? ? ? ? ? ?=0.005, p ? ?фǆч ? ? ? ? ? ?  ? ? ? ? ?чǆч ? ? ? ? ? ?=0.004, p ? ? ? ? ? ?фǆч ? ? ? ? ? ?224 
 ? ? ? ? ?чǆч ? ? ? ? ? ?=0.15). 225 
226 
p=0.002
p=0.003
p=0.04
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Supplemental Tables S2: Hypermethylation in mature aggressive B-cell lymphoma 227 
Comparison of genome-wide DNA methylation within RefSeq genes (Table S2a) and 228 
hypermethylated genes associated with mature aggressive B-cell lymphoma 229 
including BL (Table S2b). 230 
 231 
Supplemental Table S2a 232 
RefSeq genes 1000 bp 
upstream 
First exon First intron Second exon Second exon 
to last exon 
Mean methylation 
(watson strand) 
0.40 0.40 0.70 0.80 0.78 
Mean methylation 
(crick strand) 
0.41 0.39 0.69 0.81 0.78 
 233 
Supplemental Table S2b 234 
Genes de novo 
methylated in 
mature aggressive 
B-cell lymphoma
13 
1000 bp 
upstream 
First exon First intron Second exon Second exon 
to last exon 
Mean methylation 
(watson strand) 
0.84 0.90 0.63 0.81 0.60 
Mean methylation 
(crick strand) 
0.84 0.90 0.66 0.84 0.63 
 235 
 236 
 237 
238 
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 239 
Supplemental Figure S8: Comparison of DAUDI and four primary proto-typic 240 
sporadic BLs based on 450K data. Barplots depict residuals 241 
(MethylationLevel(DAUDI)-MethylationLevel(primary proto-typic sporadic BLs)) of 242 
450k data based on DAUDI and four primary proto-typic sporadic BLs. Residuals are 243 
clustered by their frequency i.e. red barplots involve CpG sites having the same 244 
residual (rounded to the next decimal place) for DAUDI and one BL, green barplots 245 
involve CpG sites having the same residual (rounded to the next decimal place) for 246 
DAUDI and two BLs, darkblue barplots involve CpG sites having the same residual 247 
(rounded to the next decimal place) for DAUDI and three BLs, lightblue barplots 248 
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involve CpG sites having the same residual (rounded to the next decimal place) for 249 
DAUDI and four BLs. A high similarity of DAUDI and at least one primary proto-typic 250 
sporadic BL can be observed. 251 
252 
 22 
253 
Supplemental Figure S9: Analysis of the DNA methylation status in four (a-d) proto-254 
typic sporadic Burkitt lymphomas using Illumina 450K Methylation arrays with regard 255 
to presence and absence of transcription of the respective genes in DAUDI cells. The 256 
analysis shows that the pattern of methylation in the gene groups defined by 257 
expression in DAUDI cells is quite conserved also in primary sporadic BL with 258 
 23 
expressed genes in DAUDI being characterized by absence of DNA methylation 259 
around the TSS and increased methylation in the gene body. 260 
261 
 24 
 262 
Supplemental Figure S10: Methylation-expression correlation analyses 263 
CpG Methylation levels were averaged for annotated RefSeq gene regions and 264 
transcripts are clustered by their expression level in present and absent calls. A 265 
strong dependency of the location of CpGs related to their distance to the TSS and 266 
 25 
the transcript expression level can be observed for human data (a). Regarding the 267 
mitochondria (b), we observed an overall low DNA methylation degree independent 268 
from their expression levels. However, EBV (c) DNA methylation does not correlate 269 
within transcripts until an exƉƌĞƐƐŝŽŶůĞǀĞůŽĨ&W<Dш ? ? ? 270 
271 
 26 
REFERENCES 272 
1. Nadkarni JS, Nadkarni JJ, Clifford P, Manolov G, Fenyö EM, Klein E. 273 
Characteristics of new cell lines derived from Burkitt lymphomas. Cancer 274 
1969; 23: 64 - 79.  275 
2. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler 276 
transform. Bioinformatics 2009; 25: 1754 - 1760.  277 
3. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The 278 
sequence alignment/map format and SAMtools. Bioinformatics 2009; 25: 279 
2078 - 2079.  280 
4. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A 281 
framework for variation discovery and genotyping using next-generation DNA 282 
sequencing data. Nat Genet. 2011; 43: 491 - 498.  283 
5. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic 284 
variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: 285 
e164. Epub 2010 Jul 3. 286 
6. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. 287 
Bioconductor: open software development for computational biology and 288 
bioinformatics. Genome Biol 2004; 5: R80. Epub 2004 Sep 15. 289 
7. Leenman EE, Panzer-Grümayer RE, Fischer S, Leitch HA, Horsman DE, Lion T, 290 
et al. Rapid determination of Epstein-Barr virus latent or lytic infection in 291 
single human cells using in situ hybridization. Mod Pathol. 2004; 17: 1564 - 292 
1572.  293 
 27 
8. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. 294 
Human DNA methylomes at base resolution show widespread epigenomic 295 
differences. Nature 2009; 462: 315 - 322.  296 
9. Lamprecht B, Walter K, Kreher S, Kumar R, Hummel M, Lenze D, et al. 297 
Derepression of an endogenous long terminal repeat activates the CSF1R 298 
proto-oncogene in human lymphoma. Nat Med 2010; 16: 571 - 579, 1p 299 
following 579.  300 
10. Karimi M, Johansson S ET. Using LUMA: a Luminometric-Based Assay for 301 
Global DNA-Methylation. Epigenetics 2006; 1: 45 - 48.  302 
11. Li Y, Vinckenbosch N, Tian G, Huerta-Sanchez E, Jiang T, Jiang H, et al. 303 
Resequencing of 200 human exomes identifies an excess of low-frequency 304 
non-synonymous coding variants. Nat Genet 2010; 42: 969 - 972.  305 
12. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, et al. 306 
Targeted capture and massively parallel sequencing of 12 human exomes. 307 
Nature. 2009; 461: 272 - 276.  308 
13. Martín-Subero JI, Kreuz M, Bibikova M, Bentink S, Ammerpohl O, Wickham-309 
Garcia E, et al. New insights into the biology and origin of mature aggressive 310 
B-cell lymphomas by combined epigenomic, genomic, and transcriptional 311 
profiling. Blood 2009; 113: 2488 - 2497. 312 
Summary 
 
The scientific contribution of this thesis consists of three articles that have been published in 
Bioinformatics (Oxford Journals) and Nature Methods and the third article being under 
review at Leukemia (Nature Publishing Group), respectively. The implications of these 
articles for the field of computational epigenetics and future perspectives of this research 
area are discussed. 
The main challenge within the framework of this thesis was the development of a 
bioinformatics tool for bisulfite sequencing analysis. The article in Bioinformatics presents 
the bioinformatics tool B-SOLANA for the analysis of DNA methylation data generated by 
two-base encoding bisulfite sequencing on the SOLi ? ƉůĂƚĨŽƌŵ ŽĨ >ŝĨĞ dĞĐŚŶŽůŽŐŝĞƐ. 
Additionally, benchmark analyses revealed that B-SOLANA exhibits a significantly higher 
sensitivity and specificity compared to other software approaches which were developed at 
the same time. The review article in Nature Methods summarizes challenges of bisulfite 
sequencing analysis as they appear on different high-throughput sequencing platforms. 
Especially primary analyses including the quality control and mapping of raw sequences are 
discussed. Furthermore, the article debates the effect of sequencing errors and 
contaminations on inferred DNA methylation levels and recommends the most appropriate 
way to analyze this type of data. This review is a helpful reference for the analysis of DNA 
methylation by high-throughput sequencing, a currently rapidly developing research area. 
The third article, which has been submitted to Leukemia, comprises the analysis of a DNA 
methylome of the DAUDI cell line at single base resolution. On the genetic level, this 
endemic Burkitt Lymphoma cell line is characterized by the presence of the hallmark IG-MYC 
translocation. Recent publications about this cell line suggested a high number of DNA 
methylation changes. However, until now only array-based studies were published, which 
have concentrated their focus on loci-specific DNA methylation patterns. We showed that 
the mechanisms of DNA methylation associated with transcriptional regulation in 
lymphomas go by far beyond the usually studied promoter methylation. Furthermore, we 
characterized the DNA methylome of the mitochondria and the Epstein-Barr virus, whereas 
upregulation of the latter has already been identified in DAUDI before. As the DAUDI cell 
line is used over decades in many laboratories throughout the world, the obtained 
methylome data prove valuable as a  ?ƌĞĨĞƌĞŶĐĞ ĞƉŝŐĞŶŽŵĞ ? ĨŽƌ ĨƵƚƵƌĞ ƐƚƵĚŝĞƐ ?
Zusammenfassung 
 
Die Grundlage dieser Dissertation bilden drei Publikationen, die in den Fachjournalen 
Bioinformatics (Oxford Journals) und Nature Methods erschienen sind, während der dritte 
Artikel zur Zeit bei Leukemia (Nature Publishing Group) begutachtet wird. Die Ergebnisse der 
beiden Veröffentlichungen und des eingereichten Manuskriptes werden in die aktuelle 
epigenetische Forschung integriert. Abschließend wird ein Ausblick auf mögliche zukünftige 
epigenetische Forschungsschwerpunkte gegeben.  
Die Problemstellung dieser Arbeit war die Entwicklung eines bioinformatischen Programmes 
zur Analyse von Bisulfit-^ĞƋƵĞŶǌŝĞƌƵŶŐƐĚĂƚĞŶ ĚĞƌ ^K>ŝ ? ,ŽĐŚĚƵƌĐŚƐĂƚǌƚĞĐŚŶŽůŽŐŝĞ ǀŽŶ
Life Technologies. Dazu wurde das Programm B-SOLANA entwickelt, welches in 
Bioinformatics publiziert wurde. Benchmark-Analysen zu B-SOLANA und weiteren 
Programmen belegen die hohe Sensitivität und Spezifizität unseres Ansatzes. Der Artikel in 
Nature Methods fasst die Herausforderungen von Bisulfit-Sequenzierungsanalysen mittels 
unterschiedlicher Technologien zusammen. Insbesondere werden Primäranalysen zur 
Qualitätskontrolle und dem Mapping von Rohsequenzen diskutiert. Hierbei können 
Sequenzierungsfehler und Kontaminationen zu fehlerhaften DNA Methylierungsergebnissen 
führen. Wir erläutern Ansätze zur Detektion und Qualitätskontrolle dieser negativen 
Einflussfaktoren. 
Der bei Leukemia eingereichte Artikel beinhaltet die Analyse des basengenauen DAUDI 
Methyloms, einer endemischen Burkitt-Lymphom Zelllinie. Genetische Eigenschaften, wie 
die IG-MYC Translokation, konnten bereits für DAUDI identifiziert werden. Aktuelle 
Forschungsergebnisse weisen auf epigenetische Eigenschaften dieser Zelllinie hin. Allerdings 
wurden bisher nur Array-Studien durchgeführt, die lediglich Lokus-spezifische DNA-
Methylierungsmuster untersucht haben. Korrelationsanalysen zeigen, dass Gentranskription 
komplexen Methylierungsmustern innerhalb der Promotorregion unterliegt, welche mit 
array-basierten Studien nicht identifiziert werden können. Außerdem haben wir das 
Methylom der Mitochondrien und des Epstein-Barr Viruses, welches in DAUDI im 
besonderen Ausmaß vorliegt, analysiert. Das in diesem Artikel publizierte Methylom könnte 
als  ?Referenz-ƉŝŐĞŶŽŵ “ für eine Zelllinie dienen, die in den letzten Jahrzehnten in vielen 
Laboren untersucht wurde. 
